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Summary of findings {#CD000363-sec1-0001}
===================

###### Insecticide‐treated bed nets and curtains compared to no nets for preventing malaria

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- --------------------------------- -------------------------------------- ---------------------------------------- ------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  **Insecticide‐treated bed nets and curtains (ITNs) compared to no nets for preventing malaria**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  **Patient or population:** people of all ages living in malaria transmission settings  **Setting:** Burkina Faso 1996 ([Halbluetzel 1996](#CD000363-bbs2-0004){ref-type="ref-list"}); Cameroon 1992 ([Moyou‐Somo 1995](#CD000363-bbs2-0015){ref-type="ref-list"}); Cambodia 2002 ([Sochantha 2006](#CD000363-bbs2-0023){ref-type="ref-list"}); Ghana 1995 ([Binka 1996](#CD000363-bbs2-0001){ref-type="ref-list"}); Ivory Coast 2000 ([Henry 2005](#CD000363-bbs2-0005){ref-type="ref-list"}); Kenya 1988 ([Sexton 1990](#CD000363-bbs2-0020){ref-type="ref-list"}); Kenya 1995 ([Nevill 1996](#CD000363-bbs2-0016){ref-type="ref-list"}) and 1998 ([Phillips‐Howard 2003](#CD000363-bbs2-0017){ref-type="ref-list"}); Myanmar 1999 ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}); Sierra Leone 1993 ([Marbiah 1998](#CD000363-bbs2-0014){ref-type="ref-list"}); Pakistan 1991 ([Rowland 1996](#CD000363-bbs2-0019){ref-type="ref-list"}); Tanzania 1996 ([Fraser‐Hurt 1999](#CD000363-bbs2-0003){ref-type="ref-list"})  **Intervention:** ITNs  **Comparison:** no nets                                                                                                                                                                                                                                                                       

  **Outcomes**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             **Anticipated absolute effects^\*^ (95% CI)**   **Relative effect  (95% CI)**     **Number of participants  (trials)**   **Certainty of the evidence  (GRADE)**   **Comments**                                                                                      

  **Risk with no nets**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    **Risk with ITNs**                                                                                                                                                                                                                                                  

  Child mortality from all causes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Children of all ages                            Rate ratio 0.83  (0.77 to 0.89)   200,833  (5 RCTs)                      ⊕⊕⊕⊕  HIGH^a^                            Insecticide‐treated bed nets and curtains reduce all‐cause child mortality compared to no nets.   

  32.9 per 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            27.3 per 1000  (25.3 to 29.3)                                                                                                                                                                                                                                       

  Children aged 1 to 59 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  37.8 per 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            31.4 per 1000  (29.1 to 33.6)                                                                                                                                                                                                                                       

  *Plasmodium falciparum* uncomplicated episodes^g^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        178 per 1000                                    96 per 1000  (86 to 107)          Rate ratio 0.55  (0.48 to 0.64)        35,551  (5 RCTs)                         ⊕⊕⊕⊕  HIGH^a^                                                                                     Insecticide‐treated bed nets and curtains reduce the incidence of uncomplicated episodes of *P falciparum* malaria compared to no nets.

  *Plasmodium vivax* uncomplicated episodes (cumulative incidence)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         149 per 1000                                    91 per 1000  (71 to 114)          Risk ratio 0.61  (0.48 to 0.77)        10,967  (2 RCTs)                         ⊕⊕⊕⊝  MODERATE^a,b^\                                                                              Insecticide‐treated bed nets and curtains probably reduce the incidence of uncomplicated episodes of *P vivax* malaria compared to no nets.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             *due to indirectness*                                                                             

  Any *Plasmodium* spp. uncomplicated episodes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             256 per 1000                                    128 per 1000  (72 to 231)         Rate ratio 0.50  (0.28 to 0.90)        8,395  (1 RCT)                           ⊕⊕⊝⊝  LOW^a,c,d^\                                                                                 Insecticide‐treated bed nets and curtains may reduce the incidence of uncomplicated episodes of any *Plasmodium* species compared to no nets.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             *due to indirectness*                                                                             

  *P falciparum* prevalence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                147 per 1000                                    122 per 1000  (102 to 144)        Risk ratio 0.83  (0.71 to 0.98)        18,809  (6 RCTs)                         ⊕⊕⊕⊕  HIGH^a^                                                                                     Insecticide‐treated bed nets and curtains reduce the prevalence of *P falciparum* malaria compared to no nets.

  *P vivax* prevalence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     130 per 1000                                    130 per 1000  (98 to 175)         Risk ratio 1.00  (0.75 to 1.34)        10,967  (2 RCTs)                         ⊕⊕⊝⊝  LOW^a,b,e^\                                                                                 Insecticide‐treated bed nets and curtains may have little or no effect on the prevalence of *P vivax* malaria compared to no nets.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             *due to indirectness and imprecision*                                                             

  Severe malaria episodes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  15.1 per 1000                                   8.5 per 1000  (5.7 to 12.4)       Rate ratio 0.56  (0.38 to 0.82)        31,173  (2 RCTs)                         ⊕⊕⊕⊕  HIGH^a^                                                                                     Insecticide‐treated bed nets and curtains reduce the incidence of severe malaria episodes compared to no nets.

  Anaemia (mean packed cell volume)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        31.4                                            32.7 (31.8 to 33.6)               Mean difference 1.29 (0.42 to 2.16)    11,489\                                  ⊕⊕⊕⊕  HIGH^a,f^                                                                                   Insecticide‐treated bed nets and curtains increase the mean packed cell volume compared to no nets.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    (5 RCTs)                                                                                                                                   

  \***The risk in the intervention group** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  **Abbreviations: CI:** confidence interval; **RCT:** randomized controlled trial; **ITN**: Insecticide‐treated net                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **GRADE Working Group grades of evidence**  **High certainty:** we are very confident that the true effect lies close to that of the estimate of the effect.  **Moderate certainty:** we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.  **Low certainty:** our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.  **Very low certainty:** we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- --------------------------------- -------------------------------------- ---------------------------------------- ------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------

^a^Not downgraded for indirectness: for most included studies, it is unclear whether insecticide resistance was present. The review authors judge that there is not convincing evidence that insecticide resistance would reduce the impact of ITNs on the included epidemiological outcomes. A previous review that included entomological outcomes showed the difference in mosquito mortality risk using ITNs compared with untreated nets modestly decreased as insecticide resistance increased ([Strode 2014](#CD000363-bbs2-0055){ref-type="ref-list"}). However, mosquito mortality risk remained significantly higher for ITNs than for untreated nets, regardless of the resistance status.  ^b^Downgraded one level for indirectness: most data are provided by a trial in two refugee camps in Pakistan. The second trial is in Myanmar and provides data only for children younger than 10 years. It is not clear how confidently the information can be applied to other populations.  ^c^Not downgraded for imprecision: the smallest effect size is still a sizable a reduction of 56 episodes per 1000 child‐years.  ^d^Downgraded two levels for indirectness: the evidence comes from one trial only, which was conducted in Myanmar, and in which participants were exclusively children aged younger than 10 years. It is not clear how confidently the information can be applied to other populations.  ^e^Downgraded one level for imprecision: the confidence interval includes both a sizable increase and decrease in prevalence.  ^f^Not downgraded for inconsistency: although the I^2^ of 69% indicated substantial heterogeneity, ITNs showed an increase in mean packed cell volume universally across each of the five trials.  ^g^The cumulative incidence of *P falciparum* clinical episodes was also reported ([Analysis 1.3](#CD000363-fig-00103){ref-type="fig"}: RR 0.44, 95% CI 0.31 to 0.62; moderate‐certainty evidence). As this is consistent with the effect on the incidence rate, we did not present both results in the 'Summary of findings\' table.

###### Insecticide‐treated bed nets and curtains compared to untreated nets for preventing malaria

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- --------------------------------- -------------------------------------- ---------------------------------------- ------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------
  **Insecticide‐treated bed nets and curtains (ITNs) compared to untreated nets (UTNs) for preventing malaria**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **Patient or population:** people of all ages living in malaria transmission settings  **Setting:** Colombia 1993 ([Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}); Ecuador 1992 ([Kroeger 1995 (Ecuador)](#CD000363-bbs2-0008){ref-type="ref-list"}); Gambia 1993 ([D\'Alessandro 1995](#CD000363-bbs2-0002){ref-type="ref-list"}); Gambia 1985 ([Snow 1987](#CD000363-bbs2-0022){ref-type="ref-list"}); Madagascar 1994 ([Rabarison 1995](#CD000363-bbs2-0018){ref-type="ref-list"}); Nicaragua 1996 ([Kroeger 1999](#CD000363-bbs2-0011){ref-type="ref-list"}); Peru Amazon 1992 ([Kroeger 1995 (Peru Amazon)](#CD000363-bbs2-0009){ref-type="ref-list"}); Peru Coast 1993 ([Kroeger 1995 (Peru Coast)](#CD000363-bbs2-0010){ref-type="ref-list"}); Thailand 1988 ([Kamol‐Ratanakul 1992](#CD000363-bbs2-0006){ref-type="ref-list"}); Thailand 1991 ([Luxemburger 1994](#CD000363-bbs2-0012){ref-type="ref-list"}); Venezuela 2000 ([Magris 2007](#CD000363-bbs2-0013){ref-type="ref-list"})  **Intervention:** ITNs  **Comparison:** UTNs                                                                                                                                                                                                                                                                             

  **Outcomes**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         **Anticipated absolute effects^\*^ (95% CI)**   **Relative effect  (95% CI)**     **Number of participants  (trials)**   **Certainty of the evidence  (GRADE)**   **Comments**                                                                                            

  **Risk with UTNs**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   **Risk with ITNs**                                                                                                                                                                                                                                                        

  Child mortality from all causes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Children of all ages                            Rate ratio 0.67  (0.36 to 1.23)   25,389  (2 RCTs)                       ⊕⊕⊕⊝  MODERATE^a,b^\                     Insecticide‐treated bed nets and curtains probably reduce all‐cause child mortality compared to UTNs.   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                *due to imprecision*                                                                                                                             

  10.6 per 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        7.1 per 1000  (3.8 to 13.0)                                                                                                                                                                                                                                               

  Children aged 1 to 59 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  24.3 per 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        16.3 per 1000\                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       (8.8 to 29.9)                                                                                                                                                                                                                                                             

  *Plasmodium falciparum* uncomplicated episodes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       289 per 1000                                    167 per 1000  (124 to 228)        Rate ratio 0.58  (0.44 to 0.78)        2,036  (5 RCTs)                          ⊕⊕⊕⊕  HIGH^a,c^                                                                                         Insecticide‐treated bed nets and curtains reduce the incidence of uncomplicated *P falciparum* malaria episodes compared to UTNs.

  *Plasmodium vivax* uncomplicated episodes ^l^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        143 per 1000                                    104 per 1000  (73 to 150)         Rate ratio 0.73  (0.51 to 1.05)        1,535  (3 RCTs)                          ⊕⊕⊝⊝  LOW^a,b,d^\                                                                                       Insecticide‐treated bed nets and curtains may reduce the incidence of uncomplicated *P vivax* malaria episodes compared to UTNs.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *due to imprecision and indirectness*                                                                   

  Any *Plasmodium* spp. uncomplicated episodes (cumulative incidence)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  69 per 1000                                     32 per 1000  (12 to 88)           Risk ratio 0.47  (0.17 to 1.28)        8,082  (2 RCTs)                          ⊕⊕⊕⊝  MODERATE^a,b,e^\                                                                                  Insecticide‐treated bed nets and curtains probably reduce the incidence of uncomplicated malaria episodes of any species compared to UTNs.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *due to imprecision*                                                                                    

  *P falciparum* prevalence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            378 per 1000                                    344 per 1000  (295 to 397)        Risk ratio 0.91  (0.78 to 1.05)        2,259  (3 RCTs)                          ⊕⊕⊕⊝  MODERATE^a,b^\                                                                                    Insecticide‐treated bed nets and curtains probably reduce the prevalence of *P falciparum* malaria compared to UTNs.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *due to imprecision*                                                                                    

  *P vivax* prevalence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 39 per 1000                                     27 per 1000  (10 to 73)           Risk ratio 0.68  (0.25 to 1.85)        350  (1 RCT)                             ⊕⊝⊝⊝  VERY LOW^a,f,g^\                                                                                  It is unclear if ITNs reduce the prevalence of *P vivax* malaria compared to UTNs.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *due to imprecision and indirectness*                                                                   

  Any *Plasmodium* spp. prevalence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     104 per 1000                                    18 per 1000  (5 to 55)            Risk ratio 0.17  (0.05 to 0.53)        924  (1 RCT)                             ⊕⊝⊝⊝  VERY LOW^a,h,i^\                                                                                  It is unclear if ITNs reduce the prevalence of malaria, regardless of species, compared to UTNs.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *due to imprecision and indirectness*                                                                   

  Anaemia (mean packed cell volume)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    32.8                                            33.3 (32.3 to 34.3)               Mean difference 0.48 (‐0.54 to 1.50)   1,909  (2 RCTs)                          ⊕⊕⊝⊝  LOW^a,j,k^\                                                                                       Insecticide‐treated bed nets and curtains may increase the mean packed cell volume compared to UTNs.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         *due to imprecision and indirectness*                                                                   

  \***The risk in the intervention group** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  **Abbreviations: CI:** confidence interval; **RCT:** randomized controlled trial; **ITN**: Insecticide‐treated net; **UTN**: untreated net                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **GRADE Working Group grades of evidence**  **High certainty:** we are very confident that the true effect lies close to that of the estimate of the effect.  **Moderate certainty:** we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.  **Low certainty:** our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.  **Very low certainty:** we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- --------------------------------- -------------------------------------- ---------------------------------------- ------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------

^a^Not downgraded for indirectness: for most included studies, it is unclear whether insecticide resistance was present. The review authors judge that there is not convincing evidence that insecticide resistance would reduce the impact of ITNs on the included epidemiological outcomes. A previous review that included entomological outcomes showed the difference in mosquito mortality risk using ITNs compared with UTNs modestly decreased as insecticide resistance increased ([Strode 2014](#CD000363-bbs2-0055){ref-type="ref-list"}). However, mosquito mortality risk remained significantly higher for ITNs than for UTNs, regardless of the resistance status.  ^b^Downgraded one level for imprecision: the confidence interval includes both a sizable decrease and an increase in the absolute number of events.  ^c^Not downgraded for inconsistency: despite significant heterogeneity (I^2^ value of 75%), each trial consistently shows an effect in favour of ITNs.  ^d^Downgraded one level for indirectness: the three studies had restrictive participant inclusion criteria. The largest weighted study included only children from a displaced persons camp in Thailand. The second study included only migrant workers also in Thailand. The third included only children younger than 10 years in Venezuela. It is not clear how confidently the information can be applied to other populations.  ^e^Not downgraded for risk of bias: although the lack of participant blinding could potentially influence the likelihood of reporting a fever, we did not consider this likely to have seriously affected the results of the studies.  ^f^Downgraded two levels for imprecision: the confidence interval includes both a sizable decrease and increase in the absolute number of events. Additionally, the small sample size and low number of events are insufficient for confidently estimating the effect size.  ^g^Downgraded two levels for indirectness: the results come from only one study, conducted only in children living in displaced persons camps in Thailand. It is not clear how confidently the information can be applied to other populations.  ^h^Downgraded one level for imprecision: the small sample size and low number of events are insufficient for confidently estimating the effect.  ^i^Downgraded two levels for indirectness: the results come from only one study, conducted only in children living in the Amazon rainforest. It is not clear how confidently the information can be applied to other populations.  ^j^Downgraded one level for indirectness: the results come from two studies that were both conducted in Gambia and only included children under the age of 10. It is not clear how confidently the information can be applied to other populations.  ^k^Downgraded one level for imprecision: the confidence interval includes both a decrease and increase in the mean packed cell volume.  ^l^The cumulative incidence of *P vivax* clinical episodes was also reported ([Analysis 2.4](#CD000363-fig-00204){ref-type="fig"}: RR 0.58, 95% CI 0.30 to 1.14, low‐certainty evidence). As this is consistent with the effect on the incidence rate, we did not present both results in the 'Summary of findings\' table.

Background {#CD000363-sec1-0002}
==========

The 2004 Cochrane Review 'Insecticide‐treated bed nets and curtains for preventing malaria' demonstrated the effectiveness of insecticide‐treated nets (ITNs) for reducing malaria prevalence, morbidity, and mortality. Incorporating information from 22 randomized controlled trials (RCTs), the review found that ITNs reduced child mortality by 17%. In areas of stable malaria transmission, ITNs also reduced parasite prevalence by 13%, uncomplicated malaria episodes by 50%, and severe malaria by 45% compared to equivalent populations with no nets ([Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"}). The World Health Organization (WHO) now recommends ITNs as a core intervention for malaria control.

Between 2010 and 2015, the estimated percentage of the at‐risk population sleeping under an ITN rose from 30% to 53%. During this time, disease incidence and malaria‐related deaths have fallen by 21% and 29%, respectively ([WHO 2016](#CD000363-bbs2-0061){ref-type="ref-list"}). Additionally, parasite prevalence in endemic sub‐Saharan Africa decreased by 50% between 2001 and 2015, with 68% of this decline attributed to the use of ITNs ([Bhatt 2015](#CD000363-bbs2-0035){ref-type="ref-list"})

Emerging insecticide resistance poses a challenge to current malaria vector control methods. There are only four classes of insecticide in use for public health, with just two mechanisms of action. A lack of funding for research into new insecticides has meant that the most recently developed class is the pyrethroids, which were developed over 40 years ago ([Ranson 2011](#CD000363-bbs2-0048){ref-type="ref-list"}). During this period, 27 countries have reported resistance to pyrethroids, and the number of susceptible *Anopheles* populations continues to decline ([Ranson 2016](#CD000363-bbs2-0049){ref-type="ref-list"}). The effectiveness of ITNs is particularly at risk, as pyrethroids are the only class of insecticide considered safe for prolonged human contact and therefore appropriate for ITN use ([Zaim 2000](#CD000363-bbs2-0065){ref-type="ref-list"}).

Insecticide resistance is commonly detected using laboratory‐based bioassays and experimental hut studies, but these do not necessarily indicate reduced ITN impact on real‐life clinical outcomes ([Ranson 2016](#CD000363-bbs2-0049){ref-type="ref-list"}). It remains unclear whether the dramatic increases in ITN use and pyrethroid resistance in the years following Lengeler's 2004 review have reduced the clinical effectiveness of ITNs. The purpose of this review update was therefore to identify, critically appraise, and summarize any trials published since the last edition of the review, incorporating modern methods for systematic reviews that allow combined analysis of cluster RCTs (cRCTs), and assessment of the certainty of the estimates of the effect of ITNs. We were able to draw on a systematic review of entomological outcomes in the presence of pyrethroid resistance from 2014 to help inform the GRADE assessments for indirectness ([Strode 2014](#CD000363-bbs2-0055){ref-type="ref-list"}).

Objectives {#CD000363-sec1-0003}
==========

The primary objective of this review was to assess the impact of ITNs on mortality and malaria morbidity, incorporating any evidence published since the previous update into new and existing analyses, and assessing the certainty of the resulting evidence using GRADE.

Methods {#CD000363-sec1-0004}
=======

Criteria for considering studies for this review {#CD000363-sec2-0001}
------------------------------------------------

### Types of studies {#CD000363-sec3-0001}

Individual RCTs and cluster RCTs (cRCTs).

### Types of participants {#CD000363-sec3-0002}

Children and adults living in malaria transmission settings.

We excluded trials examining only pregnant women, because these are reviewed elsewhere ([Gamble 2006](#CD000363-bbs2-0041){ref-type="ref-list"}), and trials examining only soldiers or travellers, as these are not representative of the general population.

### Types of interventions {#CD000363-sec3-0003}

Bed nets or curtains treated with a synthetic pyrethroid insecticide at a minimum target impregnation dose recommended by the WHO, which is as follows.

200 mg/m^2^ permethrin or etofenprox.30 mg/m^2^ cyfluthrin.20 mg/m^2^ alpha‐cypermethrin.10 mg/m^2^ deltamethrin/lambda‐cyhalothrin.

No distinction was made between insecticide‐treated bed nets and door/window/eave/wall curtains.

Control populations were those provided with either no net or with an untreated net.

### Types of outcome measures {#CD000363-sec3-0004}

#### Primary outcomes {#CD000363-sec4-0001}

Child mortality from all causes.

#### Secondary outcomes {#CD000363-sec4-0002}

Uncomplicated clinical episodes: measured using site‐specific definitions, including measured or reported fever, with or without parasitological confirmation. Measurements were usually done in the frame of prospective longitudinal studies, as a rate of episodes per unit of time (incidence). We also included trials using validated retrospective assessments in the frame of cross‐sectional surveys, providing a percentage of the population who had experienced an uncomplicated episode in a unit of time (cumulative incidence). When reported separately, *P falciparum* and *P vivax* episodes were analysed separately. We also included trials that reported the incidence of episodes of any *Plasmodium* species.Parasite prevalence: parasite prevalence due to *P falciparum* and *P vivax* was obtained using the site‐specific method for estimating parasitaemia, usually thick or thin blood smears or both. When more than one survey was done, the reported prevalence result is the average prevalence of all the surveys.Severe disease: measured using site‐specific definitions, which were based on the WHO guidelines, [WHO 1990](#CD000363-bbs2-0060){ref-type="ref-list"}, and on [Marsh 1995](#CD000363-bbs2-0046){ref-type="ref-list"}. The definition included *P falciparum* parasitaemia. Cerebral malaria was defined as coma or prostration and/or multiple seizures. The cut‐off for severe, life‐threatening anaemia was set at 5.1 g/L ([WHO 1990](#CD000363-bbs2-0060){ref-type="ref-list"}).Anaemia: expressed in mean packed cell volume (PCV), equivalent to the percentage haematocrit. Results given in grams per decilitre were converted with a standard factor of 3:1 so that 1 g/dL equals 3% PCV.The outcome measures below were considered in the previous review ([Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"}), but were not considered priority outcomes at the time of this update and were therefore not included. [Appendix 1](#CD000363-sec2-0011){ref-type="app"} details the full inclusion criteria for this previous update.High parasitaemia: measured using site‐specific definitions of high parasitaemia, provided the cut‐off value between high and low was determined prior to data analysis.Splenomegaly: measured in all trials using the Hackett scale.Anthropometric measures: standard anthropological measures (weight‐for‐age, height‐for‐age, weight‐for‐height, skinfold thickness, or mid‐upper arm circumference)

Search methods for identification of studies {#CD000363-sec2-0002}
--------------------------------------------

The previous review, [Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"}, used the search strategy outlined below to identify included studies.

The following databases were searched using the search terms and strategy described in [Appendix 2](#CD000363-sec2-0012){ref-type="app"}: Cochrane Infectious Diseases Group Specialized Register (January 2003); Cochrane Central Register of Controlled Trials (CENTRAL), published in the Cochrane Library (Issue 1, 2003); MEDLINE (1966 to October 2003); Embase (1974 to November 2002); and LILACS (Latin American and Caribbean Health Science Information database) (1982 to January 2003).The following foreign language tropical medicine journals were handsearched, covering the period from 1980 to 1997: *Bulletin OCEAC*, *Bulletin de la Société de Pathologie Exotique*, *Médecine Tropicale*, and *Revista do Instituto de Medicina Tropical de Sao Paulo*.Researchers actively involved in the field of ITNs were contacted and asked about unpublished past or ongoing work.The following agencies, which have funded ITN trials, were contacted: UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); International Development Research Centre (IDRC), Canada; the Department for International Development, UK; and the European Union Directorate‐General XII.The following manufacturers of pyrethroids used for treating netting were contacted: AgrEvo (now part of Bayer), Bayer, Cyanamid, Mitsui, Sumitomo, and Zeneca (now part of Syngenta).The following reviews were consulted: [Abdulla 1995](#CD000363-bbs2-0031){ref-type="ref-list"}; [Bermejo 1992](#CD000363-bbs2-0034){ref-type="ref-list"}; [Carnevale 1991](#CD000363-bbs2-0036){ref-type="ref-list"}; [Cattani 1997](#CD000363-bbs2-0037){ref-type="ref-list"}; [Choi 1995](#CD000363-bbs2-0038){ref-type="ref-list"}; [Curtis 1992](#CD000363-bbs2-0040){ref-type="ref-list"}; [Molyneaux 1994](#CD000363-bbs2-0047){ref-type="ref-list"}; [Rozendaal 1989](#CD000363-bbs2-0052){ref-type="ref-list"}; [Sexton 1994](#CD000363-bbs2-0053){ref-type="ref-list"}; [Voorham 1997](#CD000363-bbs2-0058){ref-type="ref-list"}; [WHO 1989](#CD000363-bbs2-0059){ref-type="ref-list"}; [Xu 1988](#CD000363-bbs2-0062){ref-type="ref-list"}; [Yadav 1997](#CD000363-bbs2-0063){ref-type="ref-list"}; and [Zimmerman 1997](#CD000363-bbs2-0066){ref-type="ref-list"}.The following books on the subject of ITNs were consulted: *Control of Disease Vectors in the Community* ([Curtis 1991](#CD000363-bbs2-0039){ref-type="ref-list"}), *Malaria: Waiting for the Vaccine* ([Targett 1991](#CD000363-bbs2-0056){ref-type="ref-list"}), and *Net Gain, a New Method for Preventing Malaria Deaths* ([Lengeler 1996](#CD000363-bbs2-0045){ref-type="ref-list"}).The reference lists of all trials identified by the above methods were consulted.

We considered for this review update all studies identified using the strategy above. Detailed below is the additional search process we undertook to identify new studies conducted since 2003.

### Electronic searches {#CD000363-sec3-0005}

We searched the following databases, using the search terms and strategy described in [Appendix 2](#CD000363-sec2-0012){ref-type="app"}: Cochrane Infectious Diseases Group Specialized Register (2003 to 18 April 2018); Cochrane Central Register of Controlled Trials (Issue 4, 2018); MEDLINE (PubMed, 2003 to 18 April 2018); Embase (Ovid, January 2003 to 18 April 2018); and LILACS (Latin American and Caribbean Health Science Information database) (2003 to 18 April 2018). To identify any ongoing trials, we also searched the World Health Organization (WHO) International Clinical Trials Registry Platform ([www.who.int/ictrp/search/en/](www.who.int/ictrp/search/en/); 18 April 2018), ClinicalTrials.gov (<https://clinicaltrials.gov/>; 18 April 2018) and the ISRCTN registry ([www.isrctn.com/](www.isrctn.com/); 18 April 2018)

### Searching other resources {#CD000363-sec3-0006}

We contacted organizations, including the WHO and the Centers for Disease Control and Prevention (CDC), for ongoing and unpublished trials. The reference lists of all trials identified by the above methods were also consulted.

Data collection and analysis {#CD000363-sec2-0003}
----------------------------

### Selection of studies {#CD000363-sec3-0007}

One review author (JP) screened the titles and abstracts of articles identified by the literature searches for potential inclusion in the review. The full‐text articles of potentially relevant trials were assessed using an eligibility form based on the inclusion criteria. Multiple publications of the same trial were included only once. Excluded studies are listed together with their reasons for exclusion in the [Characteristics of excluded studies](#CD000363-sec2-0018){ref-type="sec"} table. We have illustrated the study selection process in a PRISMA diagram (see [Figure 1](#CD000363-fig-0001){ref-type="fig"}).

![Study flow diagram.](nCD000363-AFig-FIG01){#CD000363-fig-0001}

### Data extraction and management {#CD000363-sec3-0008}

One review author (JP) extracted information from each of the included studies (identified in both search processes) using pre‐piloted electronic data extraction forms. In the case of missing data in studies from the initial search, we contacted the original study authors or the author of the original review (CL) for confirmation. In case of missing data in newly identified studies, we contacted the original study authors for clarification.

We extracted data on the following.

Trial design: type of trial; length of follow‐up; method of participant selection; sample size; and method of blinding of participants and personnel. For cRCTs we also recorded the number of clusters randomized, the number of clusters analysed, and method of adjustment for clustering.Participants: number of participants; inclusion/exclusion criteria.Intervention: description of intervention (active ingredient, dose, retreatment times, type of net); description of control.Outcomes: definition of outcomes; diagnostic method or surveillance method; passive or active case detection.Other: study location; malaria endemicity, entomological inoculation rate (EIR), primary vector species; *Plasmodium* species.

For dichotomous outcomes, we extracted the number of participants who experienced each outcome and the total number of participants in each treatment group. Where trials conducted multiple cross‐sectional surveys during the intervention period, we took an average of the numerators and denominators across the total number of surveys. We selected this procedure in order to avoid inflating the denominator artificially by adding up the participants from repeated surveys. For count data outcomes, we extracted the number of outcomes in the treatment and control groups and the total person‐time at risk in each group, or the rate ratio and a measure of variance (for example, standard error). For continuous outcomes, we extracted the mean and a measure of variance (standard deviation).

We considered the impact of ITNs on the primary outcome of child mortality from all causes likely to be age‐dependent. In addition to extracting the total number of deaths in the total study population, where possible we extracted the number of deaths and total number of children within a high‐risk age group of 1 to 59 months. This allowed an estimate for each age group of the number of deaths that can be avoided through the provision of ITNs.

### Assessment of risk of bias in included studies {#CD000363-sec3-0009}

We assessed the risk of bias for each study using the Cochrane 'Risk of bias\' tool ([Higgins 2011](#CD000363-bbs2-0044){ref-type="ref-list"}). For each included cRCT, we also assessed the five additional criteria relating specifically to cRCTs listed in Section 16.3.2 of the *Cochrane Handbook for Systematic Reviews of Interventions*. We classified judgements of risk of bias as either low, high, or unclear risk of bias. We have summarized the results of the assessment in a 'Risk of bias\' summary figure.

### Measures of treatment effect {#CD000363-sec3-0010}

We compared intervention and control data using rate ratios, risk ratios (RRs), and mean differences, and presented all results with their associated 95% confidence intervals (CIs).

### Unit of analysis issues {#CD000363-sec3-0011}

If included cRCTs had not adjusted for clustering in the analysis, we adjusted the data before combining it. We adjusted data by multiplying the standard errors by the square root of the design effect ([Higgins 2011](#CD000363-bbs2-0044){ref-type="ref-list"}), which is determined by the intracluster correlation coefficient (ICC). If the trial did not report the ICC value, we used the ICC from a similar trial that reported the same outcome ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}).

### Dealing with missing data {#CD000363-sec3-0012}

In case of missing data, we applied available‐case analysis, only including data on the known results. The denominator was the total number of participants who had data recorded for the specific outcome. For outcomes with no missing data, we performed analyses on an intention‐to‐treat basis. We included all participants randomized to each group in the analyses and analysed participants in the group to which they were randomized.

### Assessment of heterogeneity {#CD000363-sec3-0013}

We inspected forest plots for overlapping CIs and assessed statistical heterogeneity in each meta‐analysis using the I^2^ statistic and Chi^2^ test values. We considered I^2^ statistic values between 30% and 60% indicative of moderate heterogeneity; between 50% and 90% substantial heterogeneity; and between 75% and 100% considerable heterogeneity. We considered a Chi^2^ test statistic with a P value greater than 0.10 indicative of statistically significant heterogeneity. We explored clinical and methodological heterogeneity through consideration of the trial populations, methods, and interventions, and by visualization of trial results.

### Assessment of reporting biases {#CD000363-sec3-0014}

We intended to investigate reporting biases (such as publication bias) by assessing funnel plot asymmetry ([Harbord 2006](#CD000363-bbs2-0043){ref-type="ref-list"}). However, as each meta‐analysis included fewer than 10 trials, such an assessment was not possible.

### Data synthesis {#CD000363-sec3-0015}

We analysed data using Review Manager 5 ([RevMan 2014](#CD000363-bbs2-0050){ref-type="ref-list"}). As we detected no heterogeneity between the study types, we pooled data from both individual RCTs and cluster‐adjusted cRCTs in a meta‐analysis ([Richardson 2016](#CD000363-bbs2-0051){ref-type="ref-list"}).

Based on the consideration of clinical, epidemiological, and methodological heterogeneity between the trials, we used a random‐effects model.

#### Certainty of the evidence {#CD000363-sec4-0003}

We assessed the certainty of the evidence using the GRADE approach ([Guyatt 2011](#CD000363-bbs2-0042){ref-type="ref-list"}), rating each outcome as follows.

High: we are very confident that the true effect lies close to that of the estimate of the effect.Moderate: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect.Low: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.Very low: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

As all the included studies were RCTs, the evidence for each outcome started as high certainty, but could be downgraded if there were valid reasons to do so within the following five categories: risk of bias, imprecision, inconsistency, indirectness, and publication bias ([Balshem 2011](#CD000363-bbs2-0033){ref-type="ref-list"}). We summarized the certainty of the evidence for each outcome in a \'Summary of findings' table.

We drew on a review of entomological outcomes in the presence of insecticide resistance to inform our indirectness judgement in GRADE ([Strode 2014](#CD000363-bbs2-0055){ref-type="ref-list"}).

### Subgroup analysis and investigation of heterogeneity {#CD000363-sec3-0016}

We planned that if we detected substantial heterogeneity, we would perform a subgroup analysis of malaria transmission stability (stable malaria defined as an EIR of 1.0 and above, or unstable malaria defined as an EIR of less than 1.0). We additionally intended to subgroup cRCTs and individual RCTs. However, we detected substantial heterogeneity in only one meta‐analysis, and as all of the included studies were cRCTs conducted in unstable malaria areas, the subgroup analyses would not have provided any insight into the heterogeneity.

### Sensitivity analysis {#CD000363-sec3-0017}

We intended to perform a sensitivity analysis on the primary outcome to determine the effect of exclusion of trials judged to have a serious risk of bias, but we identified no such studies.

Results {#CD000363-sec1-0005}
=======

Description of studies {#CD000363-sec2-0004}
----------------------

### Results of the search {#CD000363-sec3-0018}

Our search of the databases identified a total of 333 new records. We considered 20 articles for full‐text screening following title and abstract screening. From these, we identified three articles, reporting three new trials, that met our inclusion criteria, and five new articles relating to trials included in the previous update. The search also returned five articles that were included and referenced in the previous review. The remaining seven trials were excluded.

We also screened the full texts of the 22 trials included in the previous version of the review against the inclusion criteria of the review update. Of these, we identified 20 trials for inclusion in the updated review. One record described four individual trials, conducted in separate regions of Latin America ([Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}; [Kroeger 1995 (Ecuador)](#CD000363-bbs2-0008){ref-type="ref-list"}; [Kroeger 1995 (Peru Amazon)](#CD000363-bbs2-0009){ref-type="ref-list"}; [Kroeger 1995 (Peru Coast)](#CD000363-bbs2-0010){ref-type="ref-list"}). The study selection process is shown in [Figure 1](#CD000363-fig-0001){ref-type="fig"}.

### Included studies {#CD000363-sec3-0019}

#### Trial design and location {#CD000363-sec4-0004}

Of the 23 RCTs meeting the inclusion criteria, two were individually randomized. The remaining 21 trials were cRCTs. In 15 trials, the unit of randomization was the village or larger administration unit, while six trials used households as the unit of randomization. The two individual RCTs were analysed on an intention‐to‐treat basis.

Twelve trials were conducted in sub‐Saharan Africa (Burkina Faso, Cameroon, Gambia (2), Ghana, Ivory Coast, Kenya (3), Madagascar, Sierra Leone, and Tanzania). Six trials were conducted in Latin America (Colombia, Ecuador, Nicaragua, Peru (2), and Venezuela). Four trials were conducted in the Greater Mekong subregion (Cambodia, Myanmar, and Thailand (2)), and one trial was conducted in Pakistan.

The three trials new to this update were cRCTs conducted in Cambodia, Myanmar, and Venezuela.

#### Participants {#CD000363-sec4-0005}

Eleven trials included the whole population of selected areas (typically in low‐endemicity areas), while 12 trials restricted participation to specific age groups (typically children in high‐endemicity areas). Two studies were conducted specifically in displaced‐persons camps ([Luxemburger 1994](#CD000363-bbs2-0012){ref-type="ref-list"}; [Rowland 1996](#CD000363-bbs2-0019){ref-type="ref-list"}), and one study was restricted solely to migrant workers in the area ([Kamol‐Ratanakul 1992](#CD000363-bbs2-0006){ref-type="ref-list"}).

#### Intervention {#CD000363-sec4-0006}

The trials examined the impact of insecticide‐treated bed nets (n = 19), treated hammock nets (n = 2), or treated curtains (n = 2). Additionally, one trial compared treated nets, treated curtains, and no bed nets or curtains ([Sexton 1990](#CD000363-bbs2-0020){ref-type="ref-list"}).

In some trials the intervention consisted of treating existing nets with an insecticide ('treatment of nets\'), while in other trials the investigators provided treated mosquito nets or curtains to the population ('treated nets\' and 'treated curtains\').

Most nets or curtains were treated with permethrin (200 mg/m^2^ (n = 3), 500 mg/m^2^ (n = 9), or 1000 mg/m^2^ (n = 1)). The remaining nets or curtains were treated with lambda‐cyhalothrin (10 to 30 mg/m^2^; n = 5) or deltamethrin (25 mg/m^2^; n = 4), while one study used lambda‐cyhalothrin (10 mg/m^2^) for the first year and permethrin (500 mg/m^2^) for the second year ([Kroeger 1995 (Peru Coast)](#CD000363-bbs2-0010){ref-type="ref-list"}).

Approximately half of the trials used untreated nets as a control (n = 11), while the remaining trials used no net or curtain as a control (n = 12). The usage rate of the untreated nets was high (\> 80%), except in one region in Peru, in which it was 63% ([Kroeger 1995 (Peru Coast)](#CD000363-bbs2-0010){ref-type="ref-list"}), and in the Gambia ([D\'Alessandro 1995](#CD000363-bbs2-0002){ref-type="ref-list"}), in which it varied between 50% and 90% according to the area. No usage rate was provided for [Rabarison 1995](#CD000363-bbs2-0018){ref-type="ref-list"}, [Magris 2007](#CD000363-bbs2-0013){ref-type="ref-list"}, or [Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}.

#### Outcomes {#CD000363-sec4-0007}

Seven trials reported on our primary outcome of child mortality from all causes. Of these, six were conducted in highly malaria endemic areas in sub‐Saharan Africa, and one was in conducted in Myanmar ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}). Two studies reported on the incidence of severe malaria episodes. Other outcomes reported throughout the studies included the prevalence, incidence, and cumulative incidence of each of *P falciparum*, *P vivax*, and any *Plasmodium* species.

### Excluded studies {#CD000363-sec3-0020}

Of the 20 full texts we screened from the literature search update, we excluded seven articles. Six corresponded to four trials that were not truly RCTs as they included only one cluster per arm. The seventh article reported a trial that had an inappropriate control group, as most participants in both groups were regularly using ITNs.

We also excluded two trials that were included in the previous version of the review after screening against this update\'s modified inclusion criteria. The intervention in one trial was bed nets that were not treated with insecticide ([Snow 1988](#CD000363-bbs2-0027){ref-type="ref-list"}), and the second trial did not describe the measured outcomes clearly ([Zaim 1998](#CD000363-bbs2-0030){ref-type="ref-list"}).

Further details are in the [Characteristics of excluded studies](#CD000363-sec2-0018){ref-type="sec"} table. Characteristics of the studies excluded after the previous literature search are described in [Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"}.

Risk of bias in included studies {#CD000363-sec2-0005}
--------------------------------

A detailed description of the 'Risk of bias\' assessments against the following criteria are provided in each included trial\'s 'Risk of bias\' table in the '[Characteristics of included studies](#CD000363-sec2-0017){ref-type="sec"}\' section. A summary is provided in the 'Risk of bias\' summary figure ([Figure 2](#CD000363-fig-0002){ref-type="fig"}).

!['Risk of bias\' summary: review authors\' judgements about each risk of bias item for each included study.](nCD000363-AFig-FIG02){#CD000363-fig-0002}

### Allocation {#CD000363-sec3-0021}

Though each study described the distribution of clusters to intervention or control arms as random, in several instances the specific randomization and allocation concealment processes are not described. We considered such trials to have an unclear risk of bias. Randomization procedures, where described, typically involved a public lottery, or a computer‐generated randomization sequence.

### Blinding {#CD000363-sec3-0022}

Due to the nature of the intervention, it is difficult to blind participants and study personnel to the allocated intervention group, and blinding was only conducted in five trials ([Kamol‐Ratanakul 1992](#CD000363-bbs2-0006){ref-type="ref-list"}; [Luxemburger 1994](#CD000363-bbs2-0012){ref-type="ref-list"}; [Magris 2007](#CD000363-bbs2-0013){ref-type="ref-list"}; [Rabarison 1995](#CD000363-bbs2-0018){ref-type="ref-list"}; [Snow 1987](#CD000363-bbs2-0022){ref-type="ref-list"}). However, the outcomes evaluated here, that is infection, mortality, and morbidity from malaria, were considered unlikely to be affected by participant knowledge of intervention status. We therefore assumed each of the trials to be at low risk of performance bias.

The measurement of outcomes was also considered to be unaffected by intervention knowledge for mortality, severe malaria, and prevalence of malaria as collected from cross‐sectional surveys. However, we considered that outcomes through participants\' self reporting of fever may be influenced by knowledge of the allocated intervention group. If self reported cases were confirmed by microscopy or a rapid diagnostic test, we considered the risk of detection bias to be unclear. In five trials, cases were recorded solely on the basis of self reporting, without further confirmation ([Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}; [Kroeger 1995 (Ecuador)](#CD000363-bbs2-0008){ref-type="ref-list"}; [Kroeger 1995 (Peru Amazon)](#CD000363-bbs2-0009){ref-type="ref-list"}; [Kroeger 1995 (Peru Coast)](#CD000363-bbs2-0010){ref-type="ref-list"}; [Kroeger 1999](#CD000363-bbs2-0011){ref-type="ref-list"}). We considered these trials to have a high risk of detection bias.

### Incomplete outcome data {#CD000363-sec3-0023}

We considered one trial to be at high risk of attrition bias, as the study participants included children aged 1 to 59 months, but in cross‐sectional surveys, only children aged 1 to 3 years were sampled ([Phillips‐Howard 2003](#CD000363-bbs2-0017){ref-type="ref-list"}). We judged the risk of bias to be unclear for nine trials that insufficiently reported the total numbers randomized and reasons for attrition.

### Selective reporting {#CD000363-sec3-0024}

All included trials had a low risk of reporting bias.

### Other potential sources of bias {#CD000363-sec3-0025}

We considered three trials to have a high risk of bias due to significant imbalances between intervention and control groups at baseline for one or more reported outcomes ([Fraser‐Hurt 1999](#CD000363-bbs2-0003){ref-type="ref-list"}; [Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}; [Kroeger 1995 (Peru Amazon)](#CD000363-bbs2-0009){ref-type="ref-list"}). We judged trials that did not adequately report on baseline differences as at unclear risk of bias.

Effects of interventions {#CD000363-sec2-0006}
------------------------

See: [Table 1](#CD000363-tbl-0001){ref-type="table"}; [Table 2](#CD000363-tbl-0002){ref-type="table"}

### Comparison 1: Insecticide‐treated nets versus no nets {#CD000363-sec3-0026}

Twelve trials assessed this comparison: nine in sub‐Saharan Africa, one in Cambodia, one in Myanmar and one in Pakistan

#### Child mortality from all causes {#CD000363-sec4-0008}

Five cRCTs reported child mortality from all causes. Four were conducted in highly malaria endemic areas in sub‐Saharan Africa, and one newly identified trial was conducted in Myanmar ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}). The latter trial was small and contributed to 0.1% of the overall weight of the analysis. Pooled analysis of five trials showed that mortality from all causes was 17% lower in children using an ITN than those without a net (rate ratio 0.83, 95% CI 0.77 to 0.89: 5 trials, 200,833 participants [Analysis 1.1](#CD000363-fig-00101){ref-type="fig"}). This corresponds to a saving of 5.6 lives (95% CI 3.6 to 7.6) each year for every 1000 children protected with ITNs. We assessed the mortality from all causes rate in a high‐risk age group (1 to 59 months) using data from four trials ([Binka 1996](#CD000363-bbs2-0001){ref-type="ref-list"}; [Halbluetzel 1996](#CD000363-bbs2-0004){ref-type="ref-list"}; [Nevill 1996](#CD000363-bbs2-0016){ref-type="ref-list"}; [Phillips‐Howard 2003](#CD000363-bbs2-0017){ref-type="ref-list"}), finding a saving of 6.4 lives (95% CI 4.16 to 8.69) for every 1000 children protected with ITNs.

#### Uncomplicated clinical episodes {#CD000363-sec4-0009}

Five cRCTs reported the impact of ITNs on the incidence of uncomplicated *P falciparum* episodes. Four trials were conducted in highly malaria endemic areas in sub‐Saharan Africa, and one newly identified trial was conducted in Cambodia ([Sochantha 2006](#CD000363-bbs2-0023){ref-type="ref-list"}). One trial, conducted in an area of known insecticide resistance in Ivory Coast, demonstrated a rate ratio of 0.43 (95% CI 0.25 to 0.74). Overall, the reduction in the rate of clinical episodes was almost 50% (rate ratio 0.55, 95% CI 0.48 to 0.64; 5 trials, 35,551 participants [Analysis 1.2](#CD000363-fig-00102){ref-type="fig"}). Additionally, two trials reported the impact of ITNs on the proportion of people experiencing a clinical episode of *P falciparum* within a given time frame (cumulative incidence). A similar overall reduction was seen to that of the incidence rate (RR 0.44, 95% CI 0.31 to 0.62; 2 trials, 10,967 participants, [Analysis 1.3](#CD000363-fig-00103){ref-type="fig"}).

Two cRCTs, conducted in Myanmar and Pakistan respectively, reported the impact of ITNs on the cumulative incidence of uncomplicated *P vivax* episodes. Clinical episodes of *P vivax* were reduced by 39% in people using an ITN (RR 0.61, 95% CI 0.48 to 0.77; 2 trials, 10,967 participants [Analysis 1.4](#CD000363-fig-00104){ref-type="fig"}). One trial also reported the cumulative incidence of uncomplicated episodes of any *Plasmodium* species, finding a 50% reduction in the ITN group (RR 0.50, CI 0.28 to 0.90; 1 trial, 8,395 participants, [Analysis 1.5](#CD000363-fig-00105){ref-type="fig"}) ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}).

#### Prevalence {#CD000363-sec4-0010}

Six cRCTs reported the impact of ITNs on *P falciparum* prevalence. One newly identified study that was conducted in Myanmar contributed 6.8% of the overall weight of the analysis ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}). Prevalence was reduced by 17% with ITN use (RR 0.83, 95% CI 0.71 to 0.98; 6 trials, 18,809 participants, [Analysis 1.6](#CD000363-fig-00106){ref-type="fig"}).

Two studies, conducted in Myanmar and Pakistan respectively, reported the impact of ITNs on the prevalence of *P vivax.* We found no difference between ITN and no‐nets groups (RR 1.00, 95% CI 0.75 to 1.34; 2 trials, 10,967 participants, [Analysis 1.7](#CD000363-fig-00107){ref-type="fig"}).

#### Severe malaria episodes {#CD000363-sec4-0011}

Two trials evaluated severe malarial disease as an outcome, using passive and hospital/health centre‐based case ascertainment. Due to the very low number of cases in Myanmar, the trial contributed only 0.3% of the overall weight of the analysis. Pooled analysis showed a 44% reduction in the incidence of severe malaria episodes in the ITN group (rate ratio 0.56, 95% CI 0.38 to 0.82; 2 trials, 31,173 participants, [Analysis 1.8](#CD000363-fig-00108){ref-type="fig"}).

#### Anaemia {#CD000363-sec4-0012}

Five trials reported the mean haemoglobin in ITN and no‐nets arms. Pooled analysis of the trials showed that ITNs were associated with a mean difference of a 1.29 increase in percentage PCV (95% CI 0.42 to 2.16; 5 trials, 11,489 participants, [Analysis 1.9](#CD000363-fig-00109){ref-type="fig"}).

### Comparison 2: Insecticide‐treated nets versus untreated nets {#CD000363-sec3-0027}

Eleven trials assessed this comparison: three in sub‐Saharan Africa, six in Latin America, and two in Thailand.

#### Child mortality from all causes {#CD000363-sec4-0013}

Two cRCTs, conducted in highly malaria endemic areas in sub‐Saharan Africa, reported child mortality from all causes. Pooled analysis of the trials showed that mortality from all causes was 33% lower in children using an ITN than in those using an untreated net, but as the CI includes no effect, the result is not statistically significant (rate ratio 0.67, 95% CI 0.36 to 1.23; 2 trials, 25,389 participants, [Analysis 2.1](#CD000363-fig-00201){ref-type="fig"}). This corresponds to a saving of 3.5 lives (95% CI ‐2.4 to 6.8) each year for every 1000 children protected with ITNs. The mortality from all causes rate in a high‐risk age group (1 to 59 months) was determined using data from one trial ([D\'Alessandro 1995](#CD000363-bbs2-0002){ref-type="ref-list"}). In this group, the saving is 8.0 lives (95% CI ‐5.6 to 15.57) for every 1000 children protected with ITNs.

#### Uncomplicated clinical episodes {#CD000363-sec4-0014}

Four cRCTs and one individual RCT reported the impact of ITNs on the incidence of uncomplicated *P falciparum* episodes. The overall analysis showed that ITNs contributed to a 42% reduction in the rate of clinical episodes (rate ratio 0.58, 95% CI 0.44 to 0.78; 5 trials, 2,036 participants, [Analysis 2.2](#CD000363-fig-00202){ref-type="fig"}).

Two cRCTs and one individual RCT, conducted in Thailand (two) and Venezuela, reported the incidence of uncomplicated *P vivax* episodes. The overall decrease in the rate of clinical episodes of *P vivax* in people using an ITN was not statistically significant (rate ratio 0.73, 95% CI 0.51 to 1.05; 3 trials, 1,535 participants, [Analysis 2.3](#CD000363-fig-00203){ref-type="fig"}). The reduction seen in the cumulative incidence of uncomplicated episodes of *P vivax,* reported by three trials in Latin America, was also not statistically significant (RR 0.59, CI 0.30 to 1.18; 3 trials, 23,506 participants, [Analysis 2.4](#CD000363-fig-00204){ref-type="fig"}). Two trials also reported the cumulative incidence of uncomplicated episodes of any *Plasmodium* species, reporting a reduction that was not statistically significant (RR 0.47, 95% CI 0.17 to 1.28, 2 trials, 8,082 participants, [Analysis 2.5](#CD000363-fig-00205){ref-type="fig"}).

#### Prevalence {#CD000363-sec4-0015}

Two cRCTs in sub‐Saharan Africa and one individual RCT in a displaced persons camp in Thailand (accounting for 3.3% of the overall weight of the analysis) reported the impact of ITNs versus untreated nets on prevalence of *P falciparum*. Pooled analysis showed that the reduction in prevalence was not significant (RR 0.91, 95% CI 0.78 to 1.05; 3 trials, 2,259 participants, [Analysis 2.6](#CD000363-fig-00206){ref-type="fig"}).

The trial conducted in Thailand also reported a reduction in *P vivax* prevalence that was not statistically significant (RR 0.68, 95% CI 0.25 to 1.85; 1 trial, 350 participants, [Analysis 2.7](#CD000363-fig-00207){ref-type="fig"}; [Luxemburger 1994](#CD000363-bbs2-0012){ref-type="ref-list"}), and one trial reported a massive reduction in the prevalence of any *Plasmodium* species (RR 0.17, 0.05 to 0.53; 1 trial, 924 participants, [Analysis 2.8](#CD000363-fig-00208){ref-type="fig"}; [Magris 2007](#CD000363-bbs2-0013){ref-type="ref-list"}). However the results are of limited value as there was only a single trial in each analysis.

#### Severe malaria episodes {#CD000363-sec4-0016}

No trials evaluating this comparison reported the outcome of severe malaria episodes.

#### Anaemia {#CD000363-sec4-0017}

Three cRCTs reported the mean haemoglobin in ITN and untreated‐net study arms. For two studies, information on the mean PCV, total number sampled, and standard deviation were all available, permitting pooling of the data in a meta‐analysis ([D\'Alessandro 1995](#CD000363-bbs2-0002){ref-type="ref-list"}; [Snow 1987](#CD000363-bbs2-0022){ref-type="ref-list"}). Pooled analysis showed that ITNs were associated with a mean difference of a 0.48 increase in the percentage PCV that was not statistically significant (95% CI ‐0.54 to 1.50; 2 trials, 1,909 participants, [Analysis 2.9](#CD000363-fig-00209){ref-type="fig"}).

The third trial also reported the mean haemoglobin in both arms over two surveys. This trial reported a variable impact of ITNs compared to untreated nets, with a mean PCV difference of ‐1.2 (624 participants) in the first survey and +1.5 (516 participants) in the second survey.

Discussion {#CD000363-sec1-0006}
==========

Summary of main results {#CD000363-sec2-0007}
-----------------------

We identified three new trials for inclusion that have been published since the previous version of this review ([Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"}). The new trials did not affect the conclusions of our review. Each reported outcome showed a trend that favoured ITNs, both in comparison to no nets (see [Table 1](#CD000363-tbl-0001){ref-type="table"}) and untreated nets (see [Table 2](#CD000363-tbl-0002){ref-type="table"}). Insecticide‐treated nets were shown to reduce child mortality from all causes by almost one‐fifth compared to children sleeping without a net (high‐certainty evidence). Uncomplicated clinical episodes of malaria were reduced by almost one‐half (high‐certainty evidence) and severe malaria episodes were also reduced by more than 40% (high‐certainty evidence). The prevalence of*P falciparum* was reduced by 17% (high‐certainty evidence), although a pooled analysis of two trials showed no impact on prevalence of *P vivax* (low‐certainty evidence). We found similar results when ITNs were compared to untreated nets, with child mortality from all causes reduced by one‐third (moderate‐certainty evidence). Uncomplicated clinical episodes of *P falciparum* and *P vivax* were reduced by 42% (high‐certainty evidence) and 27% (low‐certainty evidence), respectively. Reductions in the prevalence of *P falciparum* and *P vivax* were not significant (moderate‐ and very low certainty evidence).

Overall completeness and applicability of evidence {#CD000363-sec2-0008}
--------------------------------------------------

Although published more recently than the studies included in the previous review, two of the newly included studies were conducted in the year 2000 ([Magris 2007](#CD000363-bbs2-0013){ref-type="ref-list"}; [Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}), and the third was conducted in 2001 ([Sochantha 2006](#CD000363-bbs2-0023){ref-type="ref-list"}). Each of the new studies was therefore conducted no later than the date of publication of the previous review, and consequently the additional insight they can provide into the effectiveness of ITNs today, in the presence of widespread insecticide resistance, is limited. For most of the included studies, it was unclear whether insecticide resistance was present. However, one included study was specifically conducted in an area of known high insecticide resistance ([Henry 2005](#CD000363-bbs2-0005){ref-type="ref-list"}). Although the study was carried out between July 1999 and June 2000, local populations of *Anopheles gambiae s.s.* were strongly resistant to pyrethroids, with a knockdown resistance (*kdr*) allelic frequency of around 90%. *Anopheles funestus*, another local primary vector, was still susceptible to these insecticides. The impact on *P falciparum* uncomplicated episodes was the only reported outcome eligible for inclusion in this review, showing a reduction in the rate of clinical episodes in the ITN group of 57%. This was in fact the greatest impact reported by any study for this outcome. Hence the study provides no evidence that ITNs became less effective in the presence of high *kdr* frequency.

### Certainty of the evidence {#CD000363-sec3-0028}

We found no convincing evidence, either in this review or in the currently available literature, that insecticide resistance would significantly affect the impact of ITNs on the epidemiological outcomes reported here. A previous review that included entomological outcomes showed that the difference between mosquito mortality risk using ITNs compared with use of untreated nets decreased modestly as insecticide resistance increased ([Strode 2014](#CD000363-bbs2-0055){ref-type="ref-list"}). However, mosquito mortality risk remained significantly higher for ITNs than for untreated nets, regardless of the resistance status. Additionally, despite reports of moderate‐to‐high pyrethroid resistance across many endemic countries, the distribution of ITNs continues to impact on malaria incidence and prevalence ([Alout 2017](#CD000363-bbs2-0032){ref-type="ref-list"}). Until there is evidence that insecticide resistance is reducing the impact of ITNs on epidemiological outcomes, we adjudge that we should not decrease our certainty in the estimate of the effect of ITNs based on the presence of insecticide resistance. A full assessment of the certainty of the evidence for each outcome is presented in the 'Summary of findings\' tables.

Potential biases in the review process {#CD000363-sec2-0009}
--------------------------------------

If included cRCTs did not adjust for clustering in the analysis, we adjusted the data before it was combined. A potential bias arises for trials that did not report the ICC value, for which we used the ICC from a similar trial that reported the same outcome ([Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}). This approximated ICC value may lead to somewhat inaccurate sizes of CIs for such trials, although the estimate of the effect would not be affected.

Agreements and disagreements with other studies or reviews {#CD000363-sec2-0010}
----------------------------------------------------------

Despite being published before most trials included in this review were conducted, [Choi 1995](#CD000363-bbs2-0038){ref-type="ref-list"}\'s meta‐analysis reported a similar impact of ITNs on the incidence of malaria infection. In comparison to participants receiving no nets, the incidence was reduced by 51%. In the subset of trials comparing ITNs to UTNs, a smaller, but still significant, reduction of 24% was seen. More recently, [Yang 2018](#CD000363-bbs2-0064){ref-type="ref-list"} conducted a meta‐regression of 39 studies published since the year 2000. The review differentiated classic ITNs, which require re‐treating at least once per year, from long‐lasting insecticide‐treated nets (LLINs), which use newer fabric technologies to remain effective for several years. The meta‐regression found that ITNs and LLINs respectively reduce the incidence of malaria by 41% and 56% when compared to no nets. Though no other outcomes were assessed in either study, the finding supports the suggestion that treated nets have remained effective at preventing malaria cases in recent decades, despite growing concerns about insecticide resistance in malaria vectors. Unlike this review, both [Choi 1995](#CD000363-bbs2-0038){ref-type="ref-list"} and [Yang 2018](#CD000363-bbs2-0064){ref-type="ref-list"} included field trials of any study design, as long as they had a concurrent control group. Importantly, the reviews did not consider that cRCTs cannot be analysed with the same methods used when interventions are allocated on an individual level. The confidence limits presented in these reviews may therefore be deceptive. The more conservative confidence intervals presented in this review, calculated in line with the design effect of the studies, provide a more dependable indication of the lowest and largest possible effect sizes.

Authors\' conclusions {#CD000363-sec1-0007}
=====================

Implications for practiceDespite the increase in insecticide resistance frequency and intensity in populations of malaria vectors across the world, the evidence for the effectiveness of ITNs for reducing malaria‐related illness and death remains strong.

Implications for researchAlthough we judge that there is currently no strong evidence that insecticide resistance is reducing the impact of ITNs on epidemiological outcomes, future research should continue to concentrate on monitoring the spread of insecticide resistance and understanding if there is a relationship between observed resistance and reduced effectiveness of insecticide‐based vector control interventions.

What\'s new {#CD000363-sec1-0013}
===========

**DateEventDescription**14 March 2019AmendedWe corrected a formatting error in the analyses under Comparison 1. The number of participants included in each study was previously displayed as 0 for all studies. We have amended the figures so that the number of participants is not shown, instead providing the cluster‐adjusted rate ratios for the estimate of the effect.

History {#CD000363-sec1-0014}
=======

Protocol first published: Issue 1, 1995  Review first published: Issue 3, 1998

**DateEventDescription**6 November 2018New citation required but conclusions have not changedWe excluded the outcomes of splenomegaly, high parasitaemia, and anthropometric measures, which were considered in the previous review ([Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"}).\
In this update we extracted mortality data for children of all ages who participated in the included studies. However, we also calculated the baseline risk in the high‐risk age group by extracting the number of deaths and total number of children aged 1 to 59 months. From this we estimated the impact of ITNs on mortality in the high‐risk age group.\
For the secondary outcomes, summary risk and rate ratios were previously presented without CIs, as cluster‐adjusted CIs were not available for all trials. If an included cRCT did not adjust for clustering, we adjusted the data using an imputed design effect. The cRCTs were then meta‐analysed, and cluster‐adjusted CIs for each outcome were provided.6 November 2018New search has been performedThis is an update of the [Lengeler 2004](#CD000363-bbs2-0069){ref-type="ref-list"} review. We performed a literature search update, and included three articles, reporting three new trials, and five new articles relating to trials included in the previous update. We excluded two trials included in the previous version of the review. We assessed the certainty of the evidence using the GRADE approach. We assessed the risk of bias for each included study in this update using Cochrane\'s 'Risk of bias\' tool; for each included cRCT, we also assessed five additional criteria relating specifically to cRCTs.18 August 2008AmendedConverted to new review format with minor editing.19 January 2004New citation required but conclusions have not changedIssue 2, 2004  This is a major update with a revision of the text, tables, and results.  ‐ An additional 16 trials have been identified and reviewed, of which 4 were included.  ‐ The sensitivity analysis (with group 2 trials) has been removed to clarify the main results.  ‐ The literature in all sections and especially background and discussion has been updated.  ‐ Overall mortality results have been entered with the reverse variance function in order to present confidence intervals adjusted for clustering.12 January 2004New search has been performedMinor update.23 October 2003New search has been performedNew studies sought but none found.21 January 2003New search has been performedNew studies found and included or excluded.

The Academic Editor of this review update was Professor Paul Garner. We thank him for his mentorship and guidance in the production of this update.

Joseph Pryce, Marty Richardson, and the editorial base of the Cochrane Infectious Diseases Group are funded by UK aid from the UK government for the benefit of low‐ and middle‐income countries (project number 300342‐104). The views expressed do not necessarily reflect the UK government's official policies.

This work was partly supported through a grant from the Global Malaria Programme, World Health Organization.

**Study designs**Individual randomized controlled trials (RCTs) and cluster RCTs**Participants**Children and adults living in rural and urban malarious areas\
Excluded: trials examining only pregnant women and trials examining only soldiers or travellers, because they are not representative of the general population**Interventions**Bed nets or curtains treated with a synthetic pyrethroid insecticide at a minimum target impregnation dose of:\
200 mg/m^2^ permethrin or etofenprox;30 mg/m^2^ cyfluthrin;20 mg/m^2^ alpha‐cypermethrin;10 mg/m^2^ deltamethrin/lambda‐cyhalothrin.\
No distinction was made between insecticide‐treated bed nets and door/window/eave/wall curtains, which were assumed to have approximately the same impact.**Comparators**Untreated net or no net**Outcomes**Child mortality from all causes: measured using protective efficacy and rate difference.Malaria‐specific child mortality: measured using \"verbal autopsy\" reports that fulfil standard clinical criteria for a probable malaria death ([Snow 1992](#CD000363-bbs2-0054){ref-type="ref-list"}; [Todd 1994](#CD000363-bbs2-0057){ref-type="ref-list"}).Severe disease: measured using site‐specific definitions based on World Health Organization guidelines, [WHO 1990](#CD000363-bbs2-0060){ref-type="ref-list"}, and on [Marsh 1995](#CD000363-bbs2-0046){ref-type="ref-list"}. The definition included *Plasmodium falciparum* parasitaemia. Cerebral malaria was defined as coma or prostration and/or multiple seizures. The cut‐off for severe, life‐threatening anaemia was set at 5.1 g/L ([WHO 1990](#CD000363-bbs2-0060){ref-type="ref-list"}).Uncomplicated clinical episodes: measured using site‐specific definitions, including measured or reported fever, with or without parasitological confirmation. Measurements were usually done in the frame of prospective longitudinal studies, but we also considered trials using validated retrospective assessments in the frame of cross‐sectional surveys. In areas with entomological inoculation rates below 1 (unstable malaria), we considered *P falciparum* and *P vivax* episodes separately.Parasite prevalence: parasite prevalence due to *P falciparum* and *P vivax* was obtained using the site‐specific method for estimating parasitaemia, that is usually thick or thin blood smears or both. When more than one survey was done, the reported prevalence result is the average prevalence of all the surveys.

Cochrane Central Register of Controlled Trials {#CD000363-sec3-0029}
==============================================

Issue 4 of 12, April 2018:

ID Search

\#1 MeSH descriptor: \[Malaria\] explode all trees

\#2 malaria:ti,ab,kw (Word variations have been searched)

\#3 anopheles :ti, ab, kw

\#4 MeSH descriptor: \[Anopheles\] explode all trees

\#5 mosquito\* :ti, ab, kw

\#6 \#1 or \#2 or \#3 or \#4 or \#5

\#7 (Net\* or bednet\* or ITN\* or LLIN\* or \"Insecticide‐Treated Bednet\*\" or \"Insecticide‐Treated net\*\"ti, ab,kw

\#8 MeSH descriptor: Insecticide‐Treated Bednets

\#9 (Olyset\* or PermaNet\* or Veeralin):ti, ab, kw

\#10 \#7 or \#8 or \#9

\#11 \#6 and \#10 with Publication Year from 2003 to 2018

PubMed (MEDLINE) {#CD000363-sec3-0030}
================

**SearchQuery**[\#16](#16)Search (\#11) AND \#15[\#15](#15)Search (\#12) OR \#13 OR \#14 Filters: Publication date from 2003/01/01[\#14](#14)Search \"drug therapy\" \[Subheading\][\#13](#13)Search \"Randomized Controlled Trial\" \[Publication Type\] OR \"Controlled Clinical Trial\" \[Publication Type\][\#12](#12)Search randomized or placebo or randomly or trial or groups Field: Title/Abstract[\#11](#11)Search (\#9) AND \#10 Filters: Publication date from 2003/01/01;[\#10](#10)Search (\#6) OR \#7 OR \#8 Publication date from 2003/01/01;[\#9](#9)Search (\#1) OR \#2 OR \#3 OR \#4 OR \#5 Filters: Publication date from 2003/01/01;[\#8](#8)Search Olyset\* or PermaNet\* or Veeralin Field: Title/Abstract[\#7](#7)Search bednet\* or net\* or ITN\* or LLIN\* or curtain\* or \"insecticide‐treated net\*\" or \"insecticide‐treated bednet\*\" Field: Title/Abstract[\#6](#6)Search (\"Insecticide‐Treated Bednets\"\[Mesh\]) OR \"Mosquito Nets\"\[Mesh\][\#5](#5)Search malaria Field: Title/Abstract[\#4](#4)Search \"Plasmodium\"\[Mesh\][\#3](#3)Search \"Malaria\"\[Mesh\][\#2](#2)Search mosquito Field: Title/Abstract[\#1](#1)Search \"Anopheles\"\[Mesh\]

Embase {#CD000363-sec3-0031}
======

1 (malaria\* or plasmodium or anopheles).mp.

2 insecticide‐treated nets.mp. or insecticide treated net/

3 (bednet\* or net\* or ITN\* or LLIN\* or curtain\*).ab. or (bednet\* or net\* or ITN\* or LLIN\* or curtain\*).ti.

4 (Olyset\* or PermaNet\* or Veeralin).ab. or (Olyset\* or PermaNet\* or Veeralin).ti.

5 2 or 3 or 4

7 1 and 5

8 limit 7 to yr=\"2003 ‐Current\"

9 randomized controlled trial/ or controlled clinical trial/

10 ((randomi?ed ) or (singl\$ or doubl\$ or trebl\$ or tripl\$) adj (blind\$ or mask\$)) .ab. or ((randomi?ed) or (singl\$ or doubl\$ or trebl\$ or tripl\$) adj (blind\$ or mask\$)).ti.

11 9 or 10

12 8 and 11

LILACS {#CD000363-sec3-0032}
======

(tw:(bednets OR nets OR itn )) AND (tw:(malaria OR mosquito OR anopheles)) AND (tw:(randomized OR controlled OR trial OR comparison OR compared ))

ClinicalTrials.gov and WHO ICTRP {#CD000363-sec3-0033}
================================

insecticide treated nets and Malaria

**Protocol sectionRefreshed protocol**BackgroundWe updated information in the background to reflect the changes in global malaria distribution and its control since the previous update.We included further information on insecticide resistance and the need to consider this when evaluating the effectiveness of ITNs.MethodsThe primary objective of the review, to assess the impact of ITNs on mortality and malarial illness, remains relevant. The original PICO remains relevant.In the previous review, mortality data was age‐standardized across each included study by extracting only the number of deaths and total number of participants within a high‐risk age group of 1 to 59 months. To avoid the exclusion of potentially useful information, we planned to extract mortality data for children of all ages who participated in the included studies. However, we also planned to calculate the baseline risk in the high‐risk age group by extracting the number of deaths and total number of children aged 1 to 59 months. From this we estimated the impact of ITNs on mortality in the high‐risk age group.For the secondary outcomes, summary risk and rate ratios were previously presented without CIs, as cluster‐adjusted CIs were not available for all trials. If an included cRCT did not adjust for clustering, we planned to adjust the data using an imputed design effect. The cRCTs were then meta‐analysed, and cluster‐adjusted CIs for each outcome were provided.We excluded the outcomes of splenomegaly, high parasitaemia, and anthropometric measures, which were considered in the previous review ([Lengeler 2004](Lengeler 2004)), as we did not consider them priority outcomes at the time of this update.We updated our approach to assessing risk of bias, and used the standardized Cochrane\'s 'Risk of bias\' tool. For each included cRCT we also assessed five additional criteria relating specifically to cRCTs.We included all relevant trials in the meta‐analysis regardless of the local area\'s transmission intensity, and intended to subgroup between stable and unstable transmission only if we identified substantial heterogeneity.We assessed the certainty of the evidence using the GRADE approach.

###### Insecticide‐treated nets versus no nets

  Outcome or subgroup title                                                                               No. of studies   No. of participants   Statistical method                 Effect size
  ------------------------------------------------------------------------------------------------------- ---------------- --------------------- ---------------------------------- ---------------------
  [1 Child mortality from all causes](#CD000363-fig-00101){ref-type="fig"}                                5                                      Rate Ratio (Random, 95% CI)        0.83 \[0.77, 0.89\]
  [2 *P falciparum* uncomplicated episodes](#CD000363-fig-00102){ref-type="fig"}                          5                                      Rate Ratio (Random, 95% CI)        0.55 \[0.48, 0.64\]
  [3 *P falciparum* uncomplicated episodes (cumulative incidence)](#CD000363-fig-00103){ref-type="fig"}   2                                      Risk Ratio (Random, 95% CI)        0.44 \[0.31, 0.62\]
  [4 *P vivax* uncomplicated episodes (cumulative incidence)](#CD000363-fig-00104){ref-type="fig"}        2                                      Risk Ratio (Random, 95% CI)        0.61 \[0.48, 0.77\]
  [5 Any *Plasmodium spp.* uncomplicated episodes](#CD000363-fig-00105){ref-type="fig"}                   1                                      Rate Ratio (Fixed, 95% CI)         0.50 \[0.28, 0.90\]
  [6 *P falciparum* prevalence](#CD000363-fig-00106){ref-type="fig"}                                      6                                      Risk Ratio (Random, 95% CI)        0.83 \[0.71, 0.98\]
  [7 *P vivax* prevalence](#CD000363-fig-00107){ref-type="fig"}                                           2                                      Risk Ratio (Random, 95% CI)        1.00 \[0.75, 1.34\]
  [8 Severe malaria episodes](#CD000363-fig-00108){ref-type="fig"}                                        2                                      Rate Ratio (Random, 95% CI)        0.56 \[0.38, 0.82\]
  [9 Anaemia (mean packed cell volume)](#CD000363-fig-00109){ref-type="fig"}                              5                                      Mean Difference (Random, 95% CI)   1.29 \[0.42, 2.16\]

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 1 Child mortality from all causes.](nCD000363-CMP-001-01){#CD000363-fig-00101}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 2 *P falciparum* uncomplicated episodes.](nCD000363-CMP-001-02){#CD000363-fig-00102}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 3 *P falciparum* uncomplicated episodes (cumulative incidence).](nCD000363-CMP-001-03){#CD000363-fig-00103}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 4 *P vivax* uncomplicated episodes (cumulative incidence).](nCD000363-CMP-001-04){#CD000363-fig-00104}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 5 Any *Plasmodium spp.* uncomplicated episodes.](nCD000363-CMP-001-05){#CD000363-fig-00105}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 6 *P falciparum* prevalence.](nCD000363-CMP-001-06){#CD000363-fig-00106}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 7 *P vivax* prevalence.](nCD000363-CMP-001-07){#CD000363-fig-00107}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 8 Severe malaria episodes.](nCD000363-CMP-001-08){#CD000363-fig-00108}

![Analysis\
Comparison 1 Insecticide‐treated nets versus no nets, Outcome 9 Anaemia (mean packed cell volume).](nCD000363-CMP-001-09){#CD000363-fig-00109}

###### Insecticide‐treated nets versus untreated nets

  Outcome or subgroup title                                                                                      No. of studies   No. of participants   Statistical method                 Effect size
  -------------------------------------------------------------------------------------------------------------- ---------------- --------------------- ---------------------------------- ----------------------
  [1 Child mortality from all causes](#CD000363-fig-00201){ref-type="fig"}                                       2                                      Rate Ratio (Random, 95% CI)        0.67 \[0.36, 1.23\]
  [2 *P falciparum* uncomplicated episodes](#CD000363-fig-00202){ref-type="fig"}                                 5                                      Rate Ratio (Random, 95% CI)        0.58 \[0.44, 0.78\]
  [3 *P vivax* uncomplicated episodes](#CD000363-fig-00203){ref-type="fig"}                                      3                                      Rate Ratio (Random, 95% CI)        0.73 \[0.51, 1.05\]
  [4 *P vivax* uncomplicated episodes (cumulative incidence)](#CD000363-fig-00204){ref-type="fig"}               3                                      Risk Ratio (Random, 95% CI)        0.59 \[0.30, 1.18\]
  [5 Any *Plasmodium spp.* uncomplicated episodes (cumulative incidence)](#CD000363-fig-00205){ref-type="fig"}   2                                      Risk Ratio (Random, 95% CI)        0.47 \[0.17, 1.28\]
  [6 *P falciparum* prevalence](#CD000363-fig-00206){ref-type="fig"}                                             3                                      Risk Ratio (Random, 95% CI)        0.91 \[0.78, 1.05\]
  [7 *P vivax* prevalence](#CD000363-fig-00207){ref-type="fig"}                                                  1                                      Risk Ratio (Fixed, 95% CI)         0.68 \[0.25, 1.85\]
  [8 Any *Plasmodium spp.* prevalence](#CD000363-fig-00208){ref-type="fig"}                                      1                                      Risk Ratio (Fixed, 95% CI)         0.17 \[0.05, 0.53\]
  [9 Anaemia (mean packed cell volume)](#CD000363-fig-00209){ref-type="fig"}                                     2                                      Mean Difference (Random, 95% CI)   0.48 \[‐0.54, 1.50\]

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 1 Child mortality from all causes.](nCD000363-CMP-002-01){#CD000363-fig-00201}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 2 *P falciparum* uncomplicated episodes.](nCD000363-CMP-002-02){#CD000363-fig-00202}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 3 *P vivax* uncomplicated episodes.](nCD000363-CMP-002-03){#CD000363-fig-00203}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 4 *P vivax* uncomplicated episodes (cumulative incidence).](nCD000363-CMP-002-04){#CD000363-fig-00204}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 5 Any *Plasmodium spp.* uncomplicated episodes (cumulative incidence).](nCD000363-CMP-002-05){#CD000363-fig-00205}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 6 *P falciparum* prevalence.](nCD000363-CMP-002-06){#CD000363-fig-00206}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 7 *P vivax* prevalence.](nCD000363-CMP-002-07){#CD000363-fig-00207}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 8 Any *Plasmodium spp.* prevalence.](nCD000363-CMP-002-08){#CD000363-fig-00208}

![Analysis\
Comparison 2 Insecticide‐treated nets versus untreated nets, Outcome 9 Anaemia (mean packed cell volume).](nCD000363-CMP-002-09){#CD000363-fig-00209}

Characteristics of included studies \[ordered by study ID\] {#CD000363-sec2-0017}
===========================================================

[Binka 1996](#CD000363-bbs2-0001){ref-type="ref-list"}MethodsStudy design: cluster RCT (cRCT)  Unit of allocation: clusters of compounds (average 120 compounds and 1400 people/cluster)  Number of units: 48:48  Length of follow‐up: 2 years (July 1993 to June 1995).  Outcome assessment: mortality was monitored by village reporters in addition to demographic data collected every 3 months by rolling census.  Adjustment: confidence limits for the rate ratio were calculated taking into account the cluster randomization.ParticipantsNumber of participants: approximately 134,400  Inclusion criteria: children \< 10 yearsInterventionsIntervention: bed net  Insecticide and dosage: permethrin suspension (0.5 g/mL)  Retreatment: every 6 months  Usage: year 1: 97% July‐Dec, 65% Jan‐June; year 2: 72% July‐Dec, 50% Jan‐June  Control: no netOutcomesOutcomes measured: mortality rateNotesStudy location: Kassena‐Nankana district, Ghana\
EIR: 100 to 1000\
Malaria transmission: variable but high\
Main vectors: *Anopheles gambiae s.s.****Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskOpen lotteries were conducted during 21 community meetings to randomly select the clusters that were to receive the impregnated bed nets.Allocation concealment (selection bias)Low riskOpen lottery conducted.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but this was not likely to introduce bias to the outcome of mortalityBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskThis outcome was not assessed.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNot possible to blind outcome assessors, but this was not likely to introduce bias when measuring the outcome of mortalityIncomplete outcome data (attrition bias)   All outcomesLow riskHigh estimated sensitivity to all deaths in the study areaSelective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention mortality rates were comparable (23.0 and 23.5/1000 child years in the treated and control clusters respectively).\
Loss of clusters: none\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable due to cluster‐adjusted confidence intervals (CIs)[D\'Alessandro 1995](#CD000363-bbs2-0002){ref-type="ref-list"}MethodsStudy design: cRCT\
Unit of allocation: village (52 pairs of villages formed on the basis of size, after stratification by 5 geographical areas)\
Number of units: 58:52\
Length of follow‐up: 12 months\
Dropout rate unknown, but immigration/emigration rates were low (\< 5% per year).\
Mortality monitored by village reporters and yearly census. Morbidity surveys were conducted once, at the peak of the transmission season in October (n = 1520 in 50 villages). All surveys were community‐based.ParticipantsInclusion criteria: children aged 0 to 9 years and living in the area were eligible at the start, but the analysis was later restricted to children aged 1 to 59 months (n = 25,000).\
Exclusion criteria: no explicit exclusion criteria except absence of written consentInterventionsIntervention: treatment of existing bed nets in the frame of a national programme; target dose 200 mg/m^2^ permethrin; impregnation done by village health workers with the assistance of other community members and under the supervision of community health nurses; retreatment was not done during the 1‐year follow‐up period since the transmission season lasts only about 4 months.\
Control: untreated bed nets\
Usage rate around 70% in both intervention and control areas (varied between 50% and 90% according to the area).OutcomesOverall mortality (1 to 59 months)Prevalence of parasitaemia (any)Prevalence of high parasitaemia (\> 5000 trophozoites/µL)Anaemia (mean packed cell volume)Prevalence of splenomegaly (1 to 5 Hackett)Impact on nutritional status (weight‐for‐age, weight‐for‐height)NotesStudy location: 5 distinct areas spread over the whole of the Gambia (all rural areas)\
EIR: 1 to 10\
Malaria endemicity: hyperendemic\
Baseline parasite rate in children 12 to 59 months: 39%\
Main vector: *Anopheles gambiae s.l.*\
*P vivax* malaria: very low; not taken into account for analysis\
Access to health care moderately easy.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskIntervention allocation by public lottery (information provided by CL)Allocation concealment (selection bias)Low riskLow risk given the above intervention allocation procedureBlinding of participants and personnel (performance bias)   All outcomesLow riskNo blinding described, but the review authors judge that the outcomes of mortality and malaria infection were unlikely to be influenced by the lack of blinding to participants and personnelBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskThis outcome was not assessed.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNo blinding of outcome assessors described, but this was unlikely to influence the outcome measurement for mortality or parasite prevalenceIncomplete outcome data (attrition bias)   All outcomesLow riskNo missing outcome dataSelective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention mortality rates were adjusted for in the analysis.\
Loss of clusters: none\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: unclear[Fraser‐Hurt 1999](#CD000363-bbs2-0003){ref-type="ref-list"}MethodsStudy design: individual RCT  Unit of allocation: individual  Number of units: 122  Length of follow‐up: 6 months  Outcome assessment: monthly cross‐sectional surveys were conducted. Thick blood films were prepared at enrolment and at each survey.ParticipantsNumber of participants: 122  Inclusion criteria: children aged 5 to 24 months who were afebrile, not using a bed net, and not taking chloroquineInterventionsType of intervention: bed net (n = 61)  Insecticide and dosage: permethrin (500 mg/m^2^)  Retreatment: after 3 months and at the end of the trial  Usage: 97%  Control: no net (n = 61)OutcomesOutcomes measured: *P falciparum* prevalenceNotesStudy location: Kiberege, Kilombero District, southern Tanzania\
EIR: approximately 300\
Malaria transmission: intense and perennial  Main vectors: *Anopheles gambiae s.l*. and *Anopheles funestus****Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIndividuals allocated randomly, but the randomization process is not described.Allocation concealment (selection bias)Unclear riskNot describedBlinding of participants and personnel (performance bias)   All outcomesLow riskParticipants and personnel were not blinded to intervention group, but the review authors judge that this was unlikely to impact on the outcome of prevalence.Blinding of outcome assessment (detection bias)   Self‐reported feverLow riskThis outcome is not assessed.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOutcome assessors not blinded, but all participants were surveyed using objective blood smear examination, so this was unlikely to introduce bias.Incomplete outcome data (attrition bias)   All outcomesLow riskMissing outcome data very minimal and balanced in numbers across the intervention groups (1 from each).Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasHigh riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention prevalence was substantially different between the intervention group (54.1%) and control group (65%).[Halbluetzel 1996](#CD000363-bbs2-0004){ref-type="ref-list"}MethodsStudy design: cRCT\
Unit of allocation: groups of villages (8 pairs of \"clusters\" (on average 10 villages) formed on the basis of baseline mortality and geographic similarity)\
Number of units: 8:8\
Length of follow‐up: 24 months\
Mortality was monitored by village reporters and yearly census. A cross‐sectional morbidity survey was conducted once, at the peak of the transmission season in September 1995 (n = 800 in 84 villages). All surveys were community‐based.ParticipantsNumber of participants: 16,540\
Inclusion criteria: children aged 0 to 59 months living in the area (newborns were excluded from the analysis)\
Exclusion criteria: no explicit exclusion criteria except absence of written consentInterventionsIntervention: permethrin‐treated curtains on windows, door, and eaves; target dose of 1000 mg/m^2^; every house used for sleeping in the intervention clusters fitted with the curtains and retreated every 6 months\
Control: no curtainsOutcomesOverall mortality (1 to 59 months)Prevalence of parasitaemia (any)Prevalence of high parasitaemia (\> 5000 trophozoites/µL)Anaemia (mean haemoglobin in g/dL)NotesStudy location: Oubritenga Province, 30 km north of Ouagadougou, Burkina Faso, in a rural area\
EIR: 300 to 500\
Malaria endemicity: holoendemic\
Baseline parasite rate in children aged 6 to 59 months: 85%\
Main vectors: *Anopheles gambiae s.l.* and *Anopheles funestus*\
*P vivax* malaria: 0%\
Dropout rate unknown, but immigration/emigration rates were low (2% per year).\
Access to health care considered poor.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskIntervention allocation by public lottery (information provided by CL)Allocation concealment (selection bias)Low riskLow risk given the above intervention allocation procedureBlinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors do not consider this likely to introduce bias for the outcome of mortalityBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskThis outcome was not assessed.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNo blinding, but the review authors judge that the outcome and the outcome measurement were not likely to be influenced by lack of blindingIncomplete outcome data (attrition bias)   All outcomesLow riskHigh estimated sensitivity to all deaths in the study areaSelective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention mortality rates were adjusted for.\
Loss of clusters: none\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable with adjusted CIs[Henry 2005](#CD000363-bbs2-0005){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (allocation of 8 villages by paired randomization)  Number of units: 4:4  Length of follow‐up: 12 months  Outcome assessment: active case surveillance by repeated cross‐sectional surveys. Blood smear taken from every sick child, as assessed by nurse visit. Generalized estimating equation (GEE) applied for clustered data.ParticipantsNumber of participants: 426  Inclusion criteria: children aged 0 to 59 monthsInterventionsIntervention: bed net (n = 210)  Insecticide and dosage: lambda‐cyhalothrin formulated as a capsule suspension (15 mg a.i./m^2^)  Retreatment: nets dipped again after 6 months.  Usage: average coverage rate with ITNs ranged from 76.7% to 84.0% in different villages.  Control: no net (n = 216)OutcomesOutcomes measured: cumulative incidence of uncomplicated episodesNotesStudy location: Korhogo, in the North of Côte d'Ivoire. High knockdown resistance (*kdr*) resistance\
EIR: 55\
Malaria transmission: baseline prevalence of 82% in 1997 before implementation\
Main vectors: *Anopheles gambiae s.s.* and *Anopheles funestus. A gambiae* was strongly resistant to pyrethroids with a *kdr* allelic frequency of around 90%. *A funestus* was still susceptible to these insecticides.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIt is stated that the village chosen from each matched pair to receive ITN was randomly selected, but no details provided.Allocation concealment (selection bias)Unclear riskNo information provided.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but this was not likely to introduce bias to the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverUnclear riskNurse examining and recording cases of sickness at the home would have been aware of study group being visited. Unclear if technicians examining blood slides were blinded to the study groupBlinding of outcome assessment (detection bias)   All other outcomesLow riskThese outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesUnclear riskMissing outcome data were balanced across the intervention groups. Reasons for missing data given, but only as a total and not for each intervention group, possibly masking biases (58 total deaths). An imbalance between the groups may have introduced bias to the examined outcomes.Selective reporting (reporting bias)Low riskAll stated outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: baseline figures comparable for prevalence (P = 0.35) and incidence (P = 0.36).\
Loss of clusters: none\
Incorrect analysis: adjusted  Comparability with RCTs randomizing individuals: suitable for comparison[Kamol‐Ratanakul 1992](#CD000363-bbs2-0006){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: household (average 4.8 per household) stratified by malaria endemicity  Number of units: 26:28  Length of follow‐up: 8 months (November 1987 to July 1988)  Outcome assessment: morbidity rates monitored longitudinally by weekly follow‐up, at which blood slides were taken systematically.ParticipantsNumber of participants: 261  Inclusion criteria: migrant workers who had migrated to the study area more than 6 months prior to interviewInterventionsIntervention: bed net (n = 126)  Insecticide and dosage: permethrin; 500 mg/m^2^\
Retreatment: not stated  Usage: compliance 70% to 80%  Control: untreated net (n = 135) compliance 70% to 80%OutcomesOutcomes measured: incidence of clinical episodes for both *P falciparum* and *P vivax*NotesStudy location: Bothong District, Chonburi, Thailand\
EIR: low\
Malaria transmission: unstable\
Main vectors:\
*Anopheles dirus*\
% *P vivax* cases: 43%; analysed separately***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskRandomization scheme stated but not described.Allocation concealment (selection bias)Low risk1 investigator who was not otherwise involved in the care or evaluation of participants prepared the randomization.Blinding of participants and personnel (performance bias)   All outcomesLow riskParticipants were blinded to treated or untreated net.Blinding of outcome assessment (detection bias)   Self‐reported feverLow riskParticipants and outcome assessors were blinded to treated or untreated net.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOutcome assessors were blinded to treated or untreated net.Incomplete outcome data (attrition bias)   All outcomesLow riskAll randomized participants included in follow‐up.Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention history of malaria in each group did not differ significantly.[Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (22 villages were paired according to size, geographic location, net coverage, and malaria incidence at baseline; 1 village within each pair was then randomized to receive the intervention)  Number of units: 11:11  Length of follow‐up: 12 months (February 1993 to February 1994)  Outcome assessment: cross‐sectional survey carried out during the peak of the malaria season at baseline and 1 year post‐intervention.  Adjustment: noneParticipantsNumber of participants: 5632  Inclusion criteria: all inhabitants of the study area. % children under 15 = 50.6%InterventionsIntervention: community programme for sales and promotion of bed nets, and free net treatment (n = 2295)  Insecticide and dosage: lambda‐cyhalothrin treatment of existing bed nets; target dose 10 to 30 mg/m^2^  Retreatment: not stated  Usage: nearly 60% of all existing nets were treated at least once  Control: untreated net (n = 2337). Usage was very high (96% coverage).OutcomesOutcomes measured: period‐prevalence (last 2 weeks or last 4 months) of reported \"malaria episodes\" assessed during the peak of the malaria season (February to March)  Although no systematic parasitological confirmation was done, quality control procedures ensured adequate accuracy. (According to a pilot phase, about 88% to 96% of the self diagnoses were based on the same criteria as health professionals. In addition, time trends were compared to those obtained from routine data.)NotesStudy location: lower Rio San Juan, Departamente Choco on the Pacific Coast, Colombia\
EIR: \< 1\
Malaria transmission: hypoendemic and unstable with marked seasonal variation\
Main vectors: *Anopheles nevai*  % *P vivax* cases: \< 41.5%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIt was stated that villages were paired and randomly allocated, but randomization programme is not described.Allocation concealment (selection bias)Unclear riskAllocation concealment not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors judge that this lack of blinding was unlikely to have affected the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverHigh riskAs participants were not blinded, this may introduce bias for the outcome measurement, particularly as the reporting of cases is subject to participants self reporting and recalling over a 4‐month period.Blinding of outcome assessment (detection bias)   All other outcomesLow riskThese outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient reporting of attrition to permit judgementSelective reporting (reporting bias)Low riskOutcomes reported are those expected, as they are in line with a series of trials conducted by the same authors across South America.Other biasHigh riskRecruitment bias: low risk\
Baseline imbalance: 4‐month incidence rate significantly lower in intervention group.\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Kroeger 1995 (Ecuador)](#CD000363-bbs2-0008){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (14 villages were paired according to size, geographic location, net coverage, and malaria incidence at baseline; 1 village within each pair was then randomized to receive the intervention)  Number of units: 7:7  Length of follow‐up: 12 months (March 1993 to March 1994)  Outcome assessment: cross‐sectional survey carried out during the peak of the malaria season at baseline and 1 year postintervention.  Adjustment: noneParticipantsNumber of participants: 2450  Inclusion criteria: all inhabitants of the study area. % children under 15 = 51.6%InterventionsIntervention: community programme for sales and promotion of bed nets, and free net treatment (n = 1418)  Insecticide and dosage: permethrin treatment of existing bed nets; target dose 200 mg/m^2^  Retreatment: not stated  Usage: nearly 80% of all existing nets were treated at least once.  Control: untreated net (n = 1032). Usage was very high (\> 90% coverage).OutcomesOutcomes measured: period‐prevalence (last 2 weeks or last 4 months) of reported \"malaria episodes\" assessed during the peak of the malaria season (March to April)  Outcome measures were similar to [Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}.NotesStudy location: Canton Muisne, on the northern coast of Ecuador\
EIR: \< 1\
Malaria transmission: hypoendemic and unstable with marked seasonal variation\
Main vectors: *Anopheles albimanus*  % *P vivax* cases: 51%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIt was stated that villages were paired and randomly allocated, but randomization programme is not described.Allocation concealment (selection bias)Unclear riskAllocation concealment not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors judge that this lack of blinding was unlikely to have affected the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverHigh riskAs participants were not blinded, this may introduce bias for the outcome measurement, particularly as the reporting of cases is subject to participants self reporting and recalling over a 4‐month period.Blinding of outcome assessment (detection bias)   All other outcomesLow riskThese outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient reporting of attrition to permit judgementSelective reporting (reporting bias)Low riskOutcomes reported are those expected, as they are in line with a series of trials conducted by the same authors across South America.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: no significant variation in incidence rate at baseline\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Kroeger 1995 (Peru Amazon)](#CD000363-bbs2-0009){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (36 villages were paired according to size, geographic location, net coverage, and malaria incidence at baseline; 1 village within each pair was then randomized to receive the intervention)  Number of units: 18:18  Length of follow‐up: 12 months (April 1991 to April 1992)  Outcome assessment: cross‐sectional survey carried out during the peak of the malaria season at baseline and 1 year postintervention.ParticipantsNumber of participants: 5709  Inclusion criteria: all inhabitants of the study area. % children under 15 = 44.9%InterventionsIntervention: community programme for free net treatment (n = 2993); sales not necessary as usage was already very high  Insecticide and dosage: permethrin treatment of existing bed nets; target dose 200 mg/m^2^  Retreatment: not stated  Usage: nearly 61% of all existing nets treated at least once.  Control: untreated net (n = 2716). Usage was very high (95% coverage).OutcomesOutcomes measured: period‐prevalence (last 2 weeks or last 4 months) of reported \"malaria episodes\" assessed during April  Outcome measures were similar to [Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}.NotesStudy location: Tambopata District, Madre de Dios Department in the Amazonas region of Peru\
EIR: \< 1\
Malaria transmission: hypoendemic, little seasonality\
Main vectors: *Anopheles nuneztovari* and *Anopheles rangeli*  % *P vivax* cases: 100%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIt was stated that villages were paired and randomly allocated, but randomization programme is not described.Allocation concealment (selection bias)Unclear riskAllocation concealment not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors judge that this lack of blinding was unlikely to have affected the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverHigh riskAs participants were not blinded, this may introduce bias for the outcome measurement, particularly as the reporting of cases is subject to participants self reporting and recalling over a 4‐month period.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOther outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient reporting of number randomized or reasons for attrition to permit judgementSelective reporting (reporting bias)Low riskOutcomes reported are those expected, as they are in line with a series of trials conducted by the same authors across South America.Other biasHigh riskRecruitment bias: low risk\
Baseline imbalance: incidence rate was significantly higher in the intervention group at baseline.\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Kroeger 1995 (Peru Coast)](#CD000363-bbs2-0010){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (12 villages were paired according to size, geographic location, net coverage, and malaria incidence at baseline; 1 village within each pair was then randomized to receive the intervention)  Number of units: 6:6  Length of follow‐up: 2 years (June 1991 to June 1993)  Outcome assessment: cross‐sectional survey carried out during the peak of the malaria season at baseline, 1 year postintervention, and 2 years postintervention.ParticipantsNumber of participants: 6941 year 1; 6810 year 2  Inclusion criteria: all inhabitants of the study area. % children under 15 = 44.3%InterventionsIntervention: community programme for sales and promotion of bed nets, and free net treatment (n = 2859)  Insecticide and dosage: lambda‐cyhalothrin treatment of existing bed nets; target dose 10 to 30 mg/m^2^ for the first year and permethrin (500 mg/m^2^) for the second year\
Retreatment: not stated  Usage: nearly 60% of all existing nets were treated at least once.  Control: untreated net (n = 4082). Usage was very high (96% coverage).OutcomesOutcomes measured: period‐prevalence (last 2 weeks or last 4 months) of reported \"malaria episodes\" assessed during the peak of the malaria season (June to July)  Outcome measures were similar to [Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}.NotesStudy location: Communidad de Catacaos, Piura Department, northern Peru on the Pacific Coast\
EIR: \< 1\
Malaria transmission: hypoendemic and unstable with marked seasonal variation\
Main vectors: *Anopheles albimanus*  % *P vivax* cases: 100%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIt was stated that villages were paired and randomly allocated, but randomization programme is not described.Allocation concealment (selection bias)Unclear riskAllocation concealment not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors judge that this lack of blinding was unlikely to have affected the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverHigh riskAs participants were not blinded, this may introduce bias for the outcome measurement, particularly as the reporting of cases is subject to participants self reporting and recalling over a 4‐month period.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOther outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient reporting of number randomized or reasons for attrition to permit judgementSelective reporting (reporting bias)Low riskOutcomes reported are those expected, as they are in line with a series of trials conducted by the same authors across South America.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: no significant difference in incidence rate between intervention groups at baseline\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Kroeger 1999](#CD000363-bbs2-0011){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village. 12 communities were paired according to size, net coverage, socio‐economic characteristics, and malaria incidence at baseline; 1 village within each pair was then randomized to receive the intervention. For the second year, 26 communities (13 pairs) were added to the trial.  Number of units: 19:19 (only 10 pairs of clusters were used for the review analysis as the remaining 9 clusters had ITN coverage \< 31% in intervention groups)  Length of follow‐up: 12 months (postintervention study conducted in 1995 for initial 6 pairs and 1996 for following pairs)  Outcome assessment: cross‐sectional survey carried out during the peak of the malaria season at baseline and 1 year postintervention.ParticipantsNumber of participants: 5041:5815  Inclusion criteria: all inhabitants of the study areaInterventionsIntervention: community programme for sales and promotion of bed nets, and free net treatment (n = 5041)  Insecticide and dosage: lambda‐cyhalothrin treatment of existing bed nets; target dose 12.5 mg/m^2^  Retreatment: not stated  Usage: 31% to 70% of individuals used an impregnated net.  Control: untreated net (n = 5815)OutcomesOutcomes measured: period‐prevalence (last 4 months) of reported \"malaria episodes\" assessed during the peak of the malaria season (March to April)  Outcome measures were similar to [Kroeger 1995 (Colombia)](#CD000363-bbs2-0007){ref-type="ref-list"}.NotesStudy location: El Viejo Municipio, Department of Chinandega, North East Nicaragua (Pacific Coast)\
EIR: \< 1\
Malaria endemicity: hypoendemic\
Baseline parasite rate in the whole population: 8%\
Main vector: *Anopheles albimanus*\
*P vivax* malaria: 99%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskVillages were randomly assigned using random numbers.Allocation concealment (selection bias)Unclear riskAllocation concealment not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors judge that this lack of blinding was unlikely to have affected the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverHigh riskAs participants were not blinded, this may introduce bias for the outcome measurement, particularly as the reporting of cases is subject to participants self reporting and recalling over a 4‐month period.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOther outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient reporting of number randomized or reasons for attrition to permit judgementSelective reporting (reporting bias)Low riskOutcomes reported are those expected, as they are in line with a series of trials conducted by the same authors across South America.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: no significant variation in incidence rate at baseline\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Luxemburger 1994](#CD000363-bbs2-0012){ref-type="ref-list"}MethodsStudy design: individual RCT  Unit of allocation: individual (1 child per household)  Number of units: 175:175  Length of follow‐up: 6 months (August 1990 to February 1991)  Outcome assessment: passive surveillance system through camp clinics and 2 cross‐sectional surveys, one after 3 months and one after 6 months at the end of the study, following the peak of the transmission seasonParticipantsNumber of participants: 350  Inclusion criteria: children aged 5 to 14 years in the displaced persons camp. Children living too far from the schools in other small camps were excluded.InterventionsIntervention: bed net (n = 175)  Insecticide and dosage: permethrin (500 mg/m^2^)  Retreatment: not stated  Usage: 93% children under net, with 78% used correctly  Control: untreated net (n = 175) compliance similar to intervention group. The proportion of households in the village that possessed impregnated nets at baseline was about 22%.OutcomesOutcomes measured:\
Incidence of clinical episodes for both *P falciparum* and *P vivax*Prevalence of any parasitaemiaNotesStudy location: Shoklo, largest camp for Karen displaced persons on the Thai‐Burmese border\
EIR: low\
Malaria transmission: unstable\
Main vectors: *Anopheles dirus* and*Anopheles minimus* (likely main vectors)  % *P vivax* cases: 20%; 10% mixed ‐ analysed separately***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskRandomization using random numbers tableAllocation concealment (selection bias)Unclear riskAllocation concealment process not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskParticipants were blinded to treated or untreated net.Blinding of outcome assessment (detection bias)   Self‐reported feverLow riskParticipants and outcome assessors were blinded to treated or untreated net.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOutcome assessors were blinded to treated or untreated net.Incomplete outcome data (attrition bias)   All outcomesLow riskLoss of participants due to children leaving the camp; numbers were balanced across the intervention groupsSelective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: all children participating in the study were given a treatment before the beginning of the trial.[Magris 2007](#CD000363-bbs2-0013){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (paired)  Number of units: 9:9  Length of follow‐up: 2 years  Outcome assessment: continuous active (fortnightly blood smears of all villagers with fever in last 48 hours) and passive (local health centre) case detection was carried out. 2 cross‐sectional surveys carried out after intervention (6 months and 2 years) to measure prevalence.  Adjustment: adjusted rate ratio and CIs calculated to account for randomization by cluster and to adjust for potential confounding factors including age and sex.ParticipantsNumber of participants: 924  Inclusion criteria: children under 10InterventionsIntervention: insecticide‐treated hammock net (n = 429)  Insecticide and dosage: lambda‐cyhalothrin (10 mg/m^2)^\
Retreatment: every 6 months  Usage: not stated  Control: placebo‐treated hammock net (n = 495)OutcomesOutcomes measured:\
Malaria prevalenceMalaria incidenceNotesStudy location: Amazon rainforest, Venezuela\
EIR: not stated\
Malaria transmission: predominantly low with pockets of intense transmission\
Main vectors: *Anopheles darlingi*\
% *P vivax* cases: not stated***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk1 village in each pair was assigned at random by tossing a coin to the intervention or the control.Allocation concealment (selection bias)Low riskLow risk for bias with the above randomization procedureBlinding of participants and personnel (performance bias)   All outcomesLow riskParticipants were blinded to intervention or control group.Blinding of outcome assessment (detection bias)   Self‐reported feverLow riskParticipants who self reported fever were blinded to intervention or control group. Malaria cases were confirmed by blood smear examination.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNo blinding of outcome assessors described, however the review authors judge that lack of blinding was very unlikely to have impacted the measurement of prevalence through cross‐sectional survey and blood smear examinationIncomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient information to judge risk of attrition bias. 68% of the total population took part in the postintervention prevalence survey, but the number of participants missing from each intervention group is not described, and reason for missing data is not provided.Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: villages were paired by baseline incidence.\
Loss of clusters: no loss of clusters\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable for comparison[Marbiah 1998](#CD000363-bbs2-0014){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (17 villages were paired according to size, altitude, climate, and presence of a health centre; 1 village in each pair was then randomized to the intervention; children were also randomized individually to either chemoprophylaxis with pyrimethamine/dapsone or placebo. The review analysis focused on the placebo group in order to exclude the effect of chemoprophylaxis)  Number of units: 9:9  Length of follow‐up: 1 year  Outcome assessment: weekly active case detection where each child recruited into the study was visited by a field worker, and if meeting specific criteria a blood smear was examined. Anaemia was assessed through a cross‐sectional survey conducted 9 months postintervention.\
Adjustment: to account for clustering, the CIs for the protective efficacies were calculated from the mean and standard error of the log rate ratios of each pair.ParticipantsNumber of participants: 920  Inclusion criteria: children aged 3 months to 6 yearsInterventionsType of intervention: bed net (n = 470)  Insecticide and dosage: lambda‐cyhalothrin (10 mg/m^2^)\
Retreatment: not stated  Usage: not stated  Control: no net (n = 450)\
Co‐interventions: children were randomized individually to either chemoprophylaxis with pyrimethamine/dapsone (Maloprim) or placebo. Only the placebo group is included in this analysis.OutcomesOutcomes measured: incidence of malaria episodes (children aged 3 months to 6 years)NotesStudy location: 17 villages near the town of Bo, Sierra Leone\
EIR: 35\
Malaria transmission: hyperendemic  Main vectors: *Anopheles gambiae*\
% *P vivax* cases: 0%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskIntervention group was randomly allocated by a lottery.Allocation concealment (selection bias)Low riskLow risk with the above randomization processBlinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but the review authors judge that this lack of blinding was unlikely to have affected the outcome of malaria infectionBlinding of outcome assessment (detection bias)   Self‐reported feverUnclear riskChildren reporting fever during active surveillance had parasitaemia confirmed by blood smear.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNo other outcomes were assessed.Incomplete outcome data (attrition bias)   All outcomesLow riskNo missing outcome dataSelective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention incidence rate was not provided, but intervention groups were comparable for pre‐intervention mean haematocrit and splenomegaly prevalence.\
Loss of clusters: none\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable for comparison[Moyou‐Somo 1995](#CD000363-bbs2-0015){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: household (40 households with number of people varying from 5 to 25)  Number of units: 20:20  Length of follow‐up: 12 months (January to December 1992)  Outcome assessment: cross‐sectional surveys conducted every 2 months.  Adjustment: for quarter and age groupParticipantsNumber of participants: approximately 480\
Inclusion criteria: all inhabitants of the study area; children aged 15 and underInterventionsIntervention: bed net (n = approximately 240)  Insecticide and dosage: deltamethrin; target dose 25 mg/m^2^  Retreatment: after 6 months  Usage: Not described  Control: no net (n = approximately 240)OutcomesParasite prevalenceNotesStudy location: 2 villages in Kumba, South West Cameroon: Kossala (high prevalence) and Mbonge Road (low prevalence)\
EIR: 10 to 20\
Malaria transmission: intense and perennial\
Main vectors: *Anopheles gambiae s.l.*  % *P vivax* cases: 0%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskIt was stated that villages were paired and randomly allocated, but randomization programme is not described.Allocation concealment (selection bias)Unclear riskAllocation concealment not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, however the review authors judge the risk of bias to be low for the outcome of prevalenceBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskThis outcome was not assessed.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNot described if blood film examiners were blinded to the intervention group. The review authors judge the risk of bias to be low for the outcome of prevalence as the survey was cross‐sectional and the measurement is objective.Incomplete outcome data (attrition bias)   All outcomesUnclear riskInsufficient reporting of number randomized and number present at each survey to permit judgementSelective reporting (reporting bias)Low riskOutcomes reported are those that would have been expected to have been reported.Other biasUnclear riskRecruitment bias: low risk\
Baseline imbalance: unclear risk; baseline prevalence not reported\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Nevill 1996](#CD000363-bbs2-0016){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: administrative zones. Stratified by north, southeast, and southwest divisions of the study area due to significant differences in preliminary mortality and hospital presentation data  Number of units: 28:28  Length of follow‐up: 2 years  Outcome assessment: paediatric ward surveillance. Blood sample and clinical diagnosis taken.  Biannual census; data were supplemented with 6‐weekly house‐to‐house vital registration of births and deathsParticipantsNumber of participants: 22,998  Inclusion criteria: children 1 to 59 monthsInterventionsIntervention: bed net (n = 11,566)  Insecticide and dosage: permethrin suspension (0.5 g/mL)  Retreatment: nets dipped again after 6 months  Usage: 77% in intervention group; \< 1% in control  Control: no net (n = 11,432)OutcomesOutcomes measured:\
Mortality rate*P falciparum* positive admissionsSevere malaria admissions (defined as confirmed *P falciparum* parasitaemia accompanied by:coma, defined as being unable to localize a painful stimulus (assessed after 1 hour following a seizure or administration of anticonvulsants and after correction of hypoglycaemia);prostration, defined as being unable to breastfeed or sit unassisted;multiple seizures, 2 or more convulsions within 24 hours prior to admission;severe malaria anaemia, a haemoglobin of less than 5.1 g/dL, and an associated parasitaemia greater than 10,000 parasites per microlitre of blood;hyperparasitaemia, more than 20% of red cells infected;death without any of the aforementioned complications but without evidence of an alternative diagnosis.NotesStudy location: Kilifi District, Kenya\
EIR: 10 to 30\
Malaria transmission: hyperendemic. Baseline parasite rate in children 1 to 9 years: 49% in the peak season, with seasonal fluctuation\
Main vectors: *Anopheles gambiae s.l*. complex  *P vivax* malaria: 0%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskIntervention allocation by public lottery (information provided by CL)Allocation concealment (selection bias)Low riskLow risk given the above intervention allocation procedureBlinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but this was not likely to have introduced biasBlinding of outcome assessment (detection bias)   Self‐reported feverUnclear riskIncidence was determined from hospital admissions. This would involve self reporting of fever, though cases were confirmed as positive for parasitaemia.Blinding of outcome assessment (detection bias)   All other outcomesLow riskUnclear if outcome assessors were blinded, but this was not likely to have introduced bias for mortality or severe malaria measurementIncomplete outcome data (attrition bias)   All outcomesLow riskNumber randomized is based on full population census. The paper provides sufficient confidence that all deaths and hospital attendances are recorded.Selective reporting (reporting bias)Low riskAll stated outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention differences are controlled for in the adjusted risk ratios.\
Loss of clusters: none\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable for comparison[Phillips‐Howard 2003](#CD000363-bbs2-0017){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (allocation of 221 villages by open lottery; 79 clusters in Asembo, population 55,000; 142 clusters in Gem, population 70,000)  Number of units: 113:108  Length of follow‐up: 2 years (Asembo: Jan 1997 to Dec 1998; Gem: Jan 1998 to Dec 1999)  Outcome assessment: mortality was monitored by a full demographic system with biannual census. Morbidity was monitored with three cross‐sectional surveys completed at baseline (Nov 1996), midpoint (Feb to Mar 1998), and the end of the morbidity study (1998).  Adjustment: analysis for mortality rates was completed at the village level and so did not need to take clustering into account. Morbidity analysis controlled for clustering with an exchangeable correlation structure assumed for residents within a village.ParticipantsNumber of participants: approximately 18,500  Inclusion criteria: children aged 1 to 59 months who had lived in the study area for at least 1 monthInterventionsIntervention: treated bed nets  Insecticide and dosage: permethrin (500 mg/m^2^)  Retreatment: aimed to retreat bed nets every 6 months. Due to terrorist bombing of the US embassy, retreatment in some villages was delayed in 1998 and 1999.  Usage: 66% adherence  Control: no netOutcomesOutcomes measured:\
All‐cause mortality (Asembo and Gem)Prevalence of people that have clinical malaria (Asembo only)NotesStudy location: Asembo and Gem, in Nyanza Province on the shore of Lake Victoria, Kenya\
EIR: 60 to 300\
Malaria endemicity: holoendemic\
Main vector: *Anopheles gambiae* and *Anopheles funestus*\
*P vivax* malaria: 0%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskVillages were randomly assigned by public lottery.Allocation concealment (selection bias)Low riskVillage representatives chose a sealed envelope detailing their intervention group.Blinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, however the review authors judge this was unlikely to have introduced bias to the outcomes of mortality or clinical episodes of malariaBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskThis outcome was not assessed.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOutcome assessors were not blinded to intervention status of participants, but the review authors judge this was unlikely to have introduced bias to the measurement of mortality or prevalence through cross‐sectional surveys.Incomplete outcome data (attrition bias)   All outcomesHigh risk19 of 79 villages in Asembo region excluded from the cross‐sectional studies were in the southernmost area of Asembo, because longitudinal surveillance was still ongoing. The reason was unrelated to the intervention group. The study included children aged 1 to 59 months, but only children aged 1 to 3 years were sampled for the morbidity analysis.Selective reporting (reporting bias)Low riskOutcomes reported are those detailed in the study protocol.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: no significant variation in incidence rate or parasitaemia at baseline\
Loss of clusters: none\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable for comparison[Rabarison 1995](#CD000363-bbs2-0018){ref-type="ref-list"}MethodsStudy design: cRCT\
Unit of allocation: households\
Number of units: 91 households at baseline (46 intervention households, 45 controls). 78 households at the end of the study (39 intervention households, 39 controls)\
Length of follow‐up (study dates): 2 distinct periods for a total of 13 months (February 1993 to July 1993, and October 1993 to June 1994)\
Outcome assessment: passive surveillance through medical consultations at Ankazobé (Institut Pasteur)ParticipantsNumber of participants: 501 at baseline (244 in the intervention group, 257 in the control group). 431 at the end of the study (208 in the intervention group, 223 in the control group)  Inclusion criteria: households in Ankazobé district IIInterventionsIntervention: curtain nets attached to the doors and windows of bedrooms  Insecticide and dosage: deltamethrin (25 mg/m^2^)  Net retreatment: done 3 times (specific dates not provided)  Usage: not described. Likely to be high as nets are fitted by study personnel and then left  Control: untreated nets attached to the doors and windows of bedroomsOutcomesOutcomes measured: number of clinical episodes (defined as axillary body temperature over 37.5 C° plus parasitaemia \> 1500/ μL)NotesStudy location: Ankazobé (Madagascar), at altitude of 1300 m\
EIR: \< 10\
Malaria transmission (perennial, seasonal, etc.): low seasonal transmission. "Stability index" described as \<= 2.5.\
Main vector species: *Anopheles funestus* and *Anopheles gambiae*\
% *P vivax* cases: 0%***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskHouses were drawn by lottery.Allocation concealment (selection bias)Low riskLow risk of bias considering the above allocation procedureBlinding of participants and personnel (performance bias)   All outcomesLow riskSingle‐blind: participants were blinded to the impregnation status of installed curtainsBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskPassive case detection would have depended on self reporting, but as participants were blinded to intervention this was unlikely to have introduced detection bias. Cases were registered only if confirmed positive for parasitaemia.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOther outcomes were not assessed.Incomplete outcome data (attrition bias)   All outcomesLow riskLoss of households was explained as being mainly due to participants relocating following cyclones in February 1994. Loss was balanced between groups.Selective reporting (reporting bias)Low riskExpected outcomes are reported, except for data for August 1993 to September 1993, which is likely due to limited cases outside of the rain season.Other biasUnclear riskRecruitment bias: low risk\
Baseline imbalance: unclear risk. Baseline prevalence not reported.\
Loss of clusters: 13 clusters lost due to participants relocating following cyclones. These were balanced in numbers between groups.\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Rowland 1996](#CD000363-bbs2-0019){ref-type="ref-list"}MethodsStudy design: individual RCT  Unit of allocation: household (random allocation of 192 households after a first random selection of 20% of all households from a census list; the aim of this procedure was to measure the impact of treated nets in a condition of low net usage)\
Number of units: 97:95  Length of follow‐up: 6 months  Outcome assessment: prevalence survey using health centre microscopists before study (followed by treatment) and after 6 months. Passive case detection through health centre attendance dataParticipantsNumber of participants: 2792  Inclusion criteria: chosen from 2 Afghan refugee camps. All agesInterventionsType of intervention: bed net (n = 1398)  Insecticide and dosage: permethrin (0.5 g/m^2^)  Retreatment: not stated  Usage: 66% 7 nights per week, 82% 3 to 6 nights per week  Control: no net (n = 1394)OutcomesOutcomes measured:\
Incidence of malaria episodes (both *P falciparum* and *P vivax*)Prevalence of any parasitaemia (both *P falciparum* and *P vivax*)NotesStudy location: Mardan District, North West Frontier Province, North West Pakistan\
EIR: low\
Malaria transmission: unstable; 22% of individuals reported having had malaria in the past year  Main vectors: *Anopheles culicifacies and Anopheles stephensi*\
% *P vivax* cases: 77% of all cases***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskTrial families were randomly selected from the total population and then randomly divided into intervention and control groups, but randomization process is not described.Allocation concealment (selection bias)Unclear riskNot describedBlinding of participants and personnel (performance bias)   All outcomesLow riskBlinding was not possible, but the review authors judge that this was unlikely to have impacted the outcome of malaria infection.Blinding of outcome assessment (detection bias)   Self‐reported feverUnclear riskThe review authors judge that participant knowledge of their intervention group could have influenced the self reporting of fever.Blinding of outcome assessment (detection bias)   All other outcomesLow riskNo blinding of outcome assessors described, however the review authors judge that a lack of blinding was very unlikely to have impacted the measurement of prevalence through objective testsIncomplete outcome data (attrition bias)   All outcomesUnclear riskNo reason for missing outcome data provided.Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention prevalence of *P falciparum* and *P vivax* was comparable between the intervention and control group.[Sexton 1990](#CD000363-bbs2-0020){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: household  Number of units: 35 treated bed nets: 35 treated curtains: 35 control  Length of follow‐up: 15 weeks  Outcome assessment: all participants given curative treatment at enrolment. New *P falciparum* infections were determined by weekly blood smears from all family members. Only infections occurring \> 4 weeks after a treatment were considered new infections.ParticipantsNumber of participants: 481  Inclusion criteria: all agesInterventionsIntervention: bed nets (n = 166) and curtains (n = 156)  Insecticide and dosage: permethrin (0.5 g/m^2^)  Retreatment: not stated  Usage: 70% to 73%  Control: no net (n = 159)OutcomesOutcomes measured: incidence of parasitaemiaNotesStudy location: Uriri, western Kenya\
EIR: not stated\
Malaria transmission: holoendemic. 77% parasitaemia  Main vectors: *Anopheles gambiae s.l.*\
The trial compared treated bed nets, treated curtains, and no nets. As both interventions met the criteria for the review, in the analysis we added the number in the treated bed net group to the number in the treated curtain group to give the total number of cases and weeks at risk in a combined intervention group.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskStated randomized, but randomization procedure not describedAllocation concealment (selection bias)Unclear riskNot describedBlinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but this was not likely to have introduced bias to the outcome of parasitaemiaBlinding of outcome assessment (detection bias)   Self‐reported feverLow riskThe outcome was not reported.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOutcome assessors were not blinded to intervention status of participants, but the review authors judge this was unlikely to have introduced bias to the measurement of parasitaemia as all family members had a blood smear taken and the measurement is objective.Incomplete outcome data (attrition bias)   All outcomesLow riskNo reason given for missing data, but numbers lost were \< 5% (5 individuals lost from bed net group, 1 from curtain group, 0 from control group).Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasUnclear riskRecruitment bias: low risk\
Baseline imbalance: unclear. All participants received treatment at enrolment, but the baseline prevalence or incidence is not provided.\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Smithuis 2013](#CD000363-bbs2-0021){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: village (paired on the basis of geographical location)  Number of units: 10:10  Length of follow‐up: 1 year  Outcome assessment: passive case detection at local health centre. Children were followed up in 2 postintervention cross‐sectional surveys: after 5 months and at the end of the study (10 months).  Adjustment: cluster adjustment using intraclass correlation coefficient of 0.048, between‐cluster variation 0.006, and within‐cluster variation 0.12ParticipantsNumber of participants: 8395  Inclusion criteria: children under 10 years of ageInterventionsIntervention: bed net (n = 4066)  Insecticide and dosage: deltamethrin (25 mg/m^2^)\
Retreatment: not stated  Usage: not stated  Control: no net (n = 4109)OutcomesOutcomes measured:\
Malaria prevalenceMalaria incidenceNumber of deathsNumber of cases of severe malariaNotesStudy location: Rakhine State, Western Myanmar, in 2 areas: Dabhine and Myothugyi\
EIR: not stated\
Malaria transmission: predominantly low with pockets of intense transmission\
Main vectors: not stated\
% *P vivax* cases: 52%, and 2% *P falciparum*/*P vivax* mixed***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk1 village was selected from each pair using a computer‐generated random number to receive ITNs.Allocation concealment (selection bias)Low riskLow risk of bias considering the above allocation procedureBlinding of participants and personnel (performance bias)   All outcomesLow riskImpossible to blind implementers or inhabitants to intervention, but this was unlikely to have introduced bias to the outcomes of malaria infection, morbidity, or mortalityBlinding of outcome assessment (detection bias)   Self‐reported feverUnclear riskIncidence was monitored through passive case detection and depended on self reporting of a fever; cases were confirmed by microscopy.Blinding of outcome assessment (detection bias)   All other outcomesLow riskThe outcomes of mortality, severe malaria cases, and parasite prevalence measured through cross‐sectional surveys were unlikely to have been influenced by knowledge of intervention allocation.Incomplete outcome data (attrition bias)   All outcomesLow riskMissing data were balanced across the intervention groups and numbers lost were below 5%; 4.5% of the experimental group and 2.9% of the control group had moved away or were absent for the final follow‐up survey. All other participants were accounted for.Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention prevalence rates were adjusted for.\
Loss of clusters: 2 planned clusters were lost, but this was before randomization.\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: suitable for comparison[Snow 1987](#CD000363-bbs2-0022){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: household (allocation of 110 compounds was done randomly after stratification by 3 levels of \"spleen rate\": no child with enlarged spleen in household, 1 child, more than 1 child)  Number of units: 60:50  Length of follow‐up: 6 months (May to November 1987)  Outcome assessment: weekly morbidity survey of participants with those reporting a fever having a blood examination, and 2 cross‐sectional surveys: 1 before intervention in May 1987 and 1 after 6 months in November, following the peak of the transmission seasonParticipantsNumber of participants: 389  Inclusion criteria: children aged 1 to 9InterventionsIntervention: bed net (n = 205)  Insecticide and dosage: permethrin (500 mg/m^2^)  Retreatment: not described  Usage: not described  Control: placebo‐treated net (n = 184). The proportion of households in the village that possessed nets at baseline was about 98%.OutcomesOutcomes measured:\
Incidence of new episodes of malariaPrevalence of any parasitaemiaNumber of deathsNotesStudy location: Katchang, North bank of River Gambia\
EIR: 10\
Malaria transmission: hyperendemic***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskRandomization stated, but process not described.Allocation concealment (selection bias)Unclear riskAllocation concealment process not described.Blinding of participants and personnel (performance bias)   All outcomesLow riskParticipants blinded to treated or untreated net.Blinding of outcome assessment (detection bias)   Self‐reported feverLow riskOutcome assessors blinded to treated or untreated net.Blinding of outcome assessment (detection bias)   All other outcomesLow riskOutcome assessors blinded to treated or untreated net.Incomplete outcome data (attrition bias)   All outcomesLow riskLosses of participants were explained and equal between groups.Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: low, as intervention groups were stratified by prevalence\
Loss of clusters: none\
Incorrect analysis: no adjustment to CIs to account for clustering\
Comparability with RCTs randomizing individuals: not comparable unless clustering is adjusted for by review authors[Sochantha 2006](#CD000363-bbs2-0023){ref-type="ref-list"}MethodsStudy design: cRCT  Unit of allocation: villages (paired on the basis of baseline prevalence)  Number of units: 17:17  Length of follow‐up: 10 months  Outcome assessment: passive surveillance system with village malaria workers using rapid diagnostic tests (as a proxy measure to estimate malaria incidence), and blood smear cross‐sectional survey after 10 months for prevalence assessment  Adjustment: used an exchangeable correlation matrix to adjust for clusteringParticipantsNumber of participants: 10,726  Inclusion criteria: people of all agesInterventionsIntervention: bed net (n = 6106)  Insecticide and dosage: deltamethrin (25 mg/m^2^)  Retreatment: at end of follow‐up period  Usage: 87% intervention group  Control: no net (n = 4620). 14% of control group reported use of an ITN.OutcomesOutcomes measured:\
*P falciparum* prevalence*P falciparum* positive consultation rate (per person per year)NotesStudy location: Rattanakiri, North East Cambodia\
EIR: 6.0\
Malaria transmission: perennial, with a peak during the rainy season\
Main vectors: *Anopheles dirus*  % *P vivax* cases: not reported***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskComputerized random number generationAllocation concealment (selection bias)Unclear riskNot describedBlinding of participants and personnel (performance bias)   All outcomesLow riskNot possible to blind participants and personnel, but this was not likely to have introduced performance biasBlinding of outcome assessment (detection bias)   Self‐reported feverUnclear riskIt is unclear if the passive surveillance system was blinded to intervention status of participants. An objective rapid diagnostic test was used for assessment, but as this was only on participants self reporting a fever, there is the possibility of bias.Blinding of outcome assessment (detection bias)   All other outcomesLow riskIntervention group was not identified to blood smear examiners for the cross‐sectional survey.Incomplete outcome data (attrition bias)   All outcomesLow riskThe intended sample size for the cross‐sectional survey is unclear (250 per village, or 80% of population in villages with \< 250, though the size of individual villages is not described). However, the number sampled is balanced across intervention groups.Selective reporting (reporting bias)Low riskAll expected outcomes reported.Other biasLow riskRecruitment bias: low risk\
Baseline imbalance: the pre‐intervention prevalence rates were adjusted for.\
Loss of clusters: 2 planned clusters were lost, but this was before randomization.\
Incorrect analysis: adjusted\
Comparability with RCTs randomizing individuals: unclear[^1]

Characteristics of excluded studies \[ordered by study ID\] {#CD000363-sec2-0018}
===========================================================

StudyReason for exclusion[Bhatt 2012](#CD000363-bbs2-0024){ref-type="ref-list"}The study design is not appropriate as it grouped villages into just three clusters. A single cluster was randomised to each of the ITN, UTN or NN arms.[Sahu 2008](#CD000363-bbs2-0025){ref-type="ref-list"}The study design is not appropriate as it grouped villages into just three clusters. A single cluster was randomised to each of the ITN, UTN or NN arms.[Sharma 2009](#CD000363-bbs2-0026){ref-type="ref-list"}The study design is not appropriate as it grouped villages into just three clusters. A single cluster was randomised to each of the ITN, UTN or NN arms.[Snow 1988](#CD000363-bbs2-0027){ref-type="ref-list"}Comparison was between untreated nets and no nets. No participants received an ITN.[Soleimani‐Ahmadi 2012](#CD000363-bbs2-0028){ref-type="ref-list"}The study design is not appropriate as it grouped villages into just two clusters. A single cluster was randomised to each of the ITN and UTN arms.[Thang 2009](#CD000363-bbs2-0029){ref-type="ref-list"}The control group is not appropriate. The study assessed the impact of introducing insecticide treated hammocks to forest workers, compared to those not receiving hammocks. However, the participants all lived in villages with a high coverage of ITNs (88.17% in the control arm), and therefore were unsuitable to act as a control.[Zaim 1998](#CD000363-bbs2-0030){ref-type="ref-list"}Definition of measured outcome described as \"incidence of malaria\" is unclear. No other epidemiological outcomes were reported.[^2]

N/A.

Differences between revised protocol and review update {#CD000363-sec2-0016}
======================================================

Before conducting the review update, the review author team revised the original published protocol, [Lengeler 1995](#CD000363-bbs2-0067){ref-type="ref-list"} (see [Appendix 3](#CD000363-sec2-0013){ref-type="app"}). We had intended to perform two pre‐specified subgroup analyses: one that subgrouped according to malaria transmission stability and a second that subgrouped cRCTs from individual RCTs. However, we did not perform either analysis as we only detected substantial heterogeneity in one outcome, for which the contributing studies were all cRCTs in unstable malaria transmission settings. Subgrouping would therefore not have provided any insight into the heterogeneity. Otherwise, we followed the methods specified in the revised protocol ([Appendix 3](#CD000363-sec2-0013){ref-type="app"}) and [Methods](#CD000363-sec1-0004){ref-type="sec"} section.

JP conducted the search and screened studies published between 2004 and 18 April 2018; rescreened studies from the previous review against the new inclusion criteria; extracted study characteristics and outcome data from all included studies; assessed the risk of bias using new tools; conducted the meta‐analyses using cluster‐adjusted data and graded the certainty of the evidence; and prepared the final manuscript.

MR provided statistical support throughout.

CL conducted the original search and screened all studies up to 2004. For the previous review, CL extracted information from the included studies; assessed risk of bias; conducted analyses; and prepared the manuscript following the previous review\'s methodology. For this review update, CL provided guidance on data extraction; conducting the GRADE analysis; and assisted with the manuscript preparation.

All review authors have read and approved the final manuscript.

Internal sources {#CD000363-sec2-0014}
================

Liverpool School of Tropical Medicine, UK.

External sources {#CD000363-sec2-0015}
================

Department for International Development (DFID), UK.Project number 300342‐104World Health Organization (WHO), Switzerland.WHO Global Malaria Programme Agreement for Performance of Work (APW) Grant 2017 (number 709319)

JP has no known conflicts of interest.  MR has no known conflicts of interest.  CL has no known conflicts of interest.

[^1]: Abbreviations: cRCT: cluster‐randomized controlled trial; CI: confidence interval; EIR: entomological inoculation rate; ITN: insecticide‐treated net; RCT: randomized controlled trial.

[^2]: Abbreviations: ITN: insecticide‐treated net; NN: no net; UTN: untreated net.
